Anne Cunanan Ford
Associate Professor of Obstetrics and Gynecology
General obstetrics and gynecology, women's wellness promotion and preventive health, menopause and the peri-menopausal transition, vulvar dermatology
Current Appointments & Affiliations
- Associate Professor of Obstetrics and Gynecology, Obstetrics and Gynecology, Duke Women's Health Wake North, Obstetrics and Gynecology 2021
Contact Information
- 3000 Rogers Rd, Suite 310, Wake Forest, NC 27587
- DUMC Box 3840, Durham, NC 27617
-
anne.ford@duke.edu
(919) 385-2940
- Background
-
Education, Training, & Certifications
- Resident, Obstetrics & Gynecology, Emory University 1990 - 1993
- M.D., University of North Carolina - Chapel Hill 1988
- B.A., Duke University 1984
-
Medical Licensure
- 9800248. North Carolina. 1998
-
Previous Appointments & Affiliations
- Associate Professor of Obstetrics and Gynecology, Obstetrics and Gynecology, Duke Women's Health Wake North, Obstetrics and Gynecology 2018 - 2020
- Associate Professor of Obstetrics and Gynecology, Obstetrics and Gynecology, Duke Women's Health Associates, Obstetrics and Gynecology 2012 - 2018
- Assistant Professor of Obstetrics and Gynecology, Obstetrics and Gynecology, Duke Women's Health Associates, Obstetrics and Gynecology 2006 - 2012
- Chief of the Duke Women, Obstetrics and Gynecology, Duke Women's Health Associates, Obstetrics and Gynecology 2004 - 2009
- Assistant Clinical Professor of Obstetrics and Gynecology, Obstetrics and Gynecology, Duke Women's Health Associates, Obstetrics and Gynecology 2000 - 2006
- Assistant Clinical Professor in the Department of Obstetrics and Gynecology, Obstetrics and Gynecology, Clinical Science Departments 1998 - 2000
-
Leadership & Clinical Positions at Duke
-
Division Director, Duke Women's Health Wake County 2020 - present
Departmental Clinical Leadership Team 2020 - present
Division Chief, Duke Women's Health- Heritage, 2018 - 2020
Division Chief, Duke Women's Health Associates 2004 -2008
Vice Division Chief, Duke Women's Health Associates 2000 -2004
Division Chief, Duke Women's Health Specialist 1999-2000
-
Division Director, Duke Women's Health Wake County 2020 - present
- Recognition
-
In the News
-
OCT 18, 2022 Endocrine Today
-
-
Awards & Honors
- CAARE Community Leadership Award. CAARE, Inc. December 2015
- Expertise
-
Subject Headings
- Research
-
Selected Grants
- KCNK9 Imprinting in Breast Cancer Progression and Metastasis awarded by National Institutes of Health 2011 - 2015
- The Role of HER2 Signaling Networks in Early Stage Breast Cancer Initiation and Resistance to Tamoxifen Prevention awarded by UT MD Anderson Cancer Center 2009 - 2015
- Disparities in cervical cancer precursors and deregulation of imprinted genes awarded by National Institutes of Health 2010 - 2014
- Treatment of Postmenopausal Decrease Sexual Desire Dysfunction with Transdermal Testosterone Gel awarded by Josiah Charles Trent Memorial Foundation 2005 - 2008
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
Barberio, Brigida, David J. Gracie, Christopher J. Black, and Alexander C. Ford. “Efficacy of biological therapies and small molecules in induction and maintenance of remission in luminal Crohn's disease: systematic review and network meta-analysis.” Gut 72, no. 2 (February 2023): 264–74. https://doi.org/10.1136/gutjnl-2022-328052.Full Text Link to Item
-
Goodoory, Vivek C., Elspeth A. Guthrie, Cho E. Ng, Christopher J. Black, and Alexander C. Ford. “Factors associated with lower disease-specific and generic health-related quality of life in Rome IV irritable bowel syndrome.” Aliment Pharmacol Ther 57, no. 3 (February 2023): 323–34. https://doi.org/10.1111/apt.17356.Full Text Link to Item
-
Barberio, Brigida, David J. Gracie, Christopher J. Black, and Alexander C. Ford. “Impact of Baseline Disease Activity and Trial Duration on Efficacy of Biologics in Active Crohn's Disease: Meta-analysis.” Inflamm Bowel Dis, January 13, 2023. https://doi.org/10.1093/ibd/izac263.Full Text Link to Item
-
Barberio, Brigida, Pierfrancesco Visaggi, Edoardo Savarino, Nicola de Bortoli, Christopher J. Black, and Alexander C. Ford. “Comparison of acid-lowering drugs for endoscopy negative reflux disease: Systematic review and network Meta-Analysis.” Neurogastroenterol Motil 35, no. 1 (January 2023): e14469. https://doi.org/10.1111/nmo.14469.Full Text Link to Item
-
Din, Shahida, Christian P. Selinger, Christopher J. Black, and Alexander C. Ford. “Systematic review with network meta-analysis: Risk of Herpes zoster with biological therapies and small molecules in inflammatory bowel disease.” Aliment Pharmacol Ther, December 31, 2022. https://doi.org/10.1111/apt.17379.Full Text Link to Item
-
Ingrosso, Maria Rosa, Michael Camilleri, Jan Tack, Gianluca Ianiro, Christopher J. Black, and Alexander C. Ford. “Efficacy and Safety of Drugs for Gastroparesis: Systematic Review and Network Meta-analysis.” Gastroenterology, December 2022, S0016-5085(22)01398-1. https://doi.org/10.1053/j.gastro.2022.12.014.Full Text
-
Fairbrass, Keeley M., Elspeth A. Guthrie, Christopher J. Black, Christian P. Selinger, David J. Gracie, and Alexander C. Ford. “Characteristics and Effect of Anxiety and Depression Trajectories in Inflammatory Bowel Disease.” Am J Gastroenterol, November 25, 2022. https://doi.org/10.14309/ajg.0000000000002063.Full Text Link to Item
-
Black, Christopher J., Lesley A. Houghton, and Alexander C. Ford. “Latent class analysis does not support the existence of Rome IV functional bowel disorders as discrete entities.” Neurogastroenterol Motil 34, no. 11 (November 2022): e14391. https://doi.org/10.1111/nmo.14391.Full Text Link to Item
-
Fairbrass, Keeley M., P John Hamlin, David J. Gracie, and Alexander C. Ford. “Natural history and impact of irritable bowel syndrome-type symptoms in inflammatory bowel disease during 6 years of longitudinal follow-up.” Aliment Pharmacol Ther 56, no. 8 (October 2022): 1264–73. https://doi.org/10.1111/apt.17193.Full Text Link to Item
-
Fairbrass, Keeley M., P John Hamlin, David J. Gracie, and Alexander C. Ford. “Editorial: natural history of irritable bowel syndrome in inflammatory bowel disease-authors' reply.” Aliment Pharmacol Ther 56, no. 8 (October 2022): 1302–3. https://doi.org/10.1111/apt.17215.Full Text Link to Item
-
Ingrosso, Maria Rosa, Gianluca Ianiro, Judy Nee, Anthony J. Lembo, Paul Moayyedi, Christopher J. Black, and Alexander C. Ford. “Letter: efficacy of peppermint oil in irritable bowel syndrome-authors' reply.” Aliment Pharmacol Ther 56, no. 7 (October 2022): 1217–18. https://doi.org/10.1111/apt.17197.Full Text Link to Item
-
Goodoory, Vivek C., Cho Ee Ng, Christopher J. Black, and Alexander C. Ford. “Willingness to pay for medications among patients with Rome IV Irritable Bowel Syndrome.” Neurogastroenterol Motil, September 30, 2022, e14483. https://doi.org/10.1111/nmo.14483.Full Text Link to Item
-
Black, Christopher J., Peter A. Paine, Anurag Agrawal, Imran Aziz, Maria P. Eugenicos, Lesley A. Houghton, Pali Hungin, et al. “British Society of Gastroenterology guidelines on the management of functional dyspepsia.” Gut 71, no. 9 (September 2022): 1697–1723. https://doi.org/10.1136/gutjnl-2022-327737.Full Text Link to Item
-
Fairbrass, Keeley M., Jessica Lovatt, Brigida Barberio, Yuhong Yuan, David J. Gracie, and Alexander C. Ford. “Bidirectional brain-gut axis effects influence mood and prognosis in IBD: a systematic review and meta-analysis.” Gut 71, no. 9 (September 2022): 1773–80. https://doi.org/10.1136/gutjnl-2021-325985.Full Text Link to Item
-
Ford, Alexander C., Yuhong Yuan, and Paul Moayyedi. “Long-Term Impact of Helicobacter pylori Eradication Therapy on Gastric Cancer Incidence and Mortality in Healthy Infected Individuals: A Meta-Analysis Beyond 10 Years of Follow-Up.” Gastroenterology 163, no. 3 (September 2022): 754-756.e1. https://doi.org/10.1053/j.gastro.2022.05.027.Full Text Link to Item
-
Goodoory, Vivek C., Cho Ee Ng, Christopher J. Black, and Alexander C. Ford. “Impact of Rome IV irritable bowel syndrome on work and activities of daily living.” Aliment Pharmacol Ther 56, no. 5 (September 2022): 844–56. https://doi.org/10.1111/apt.17132.Full Text Link to Item
-
Goodoory, Vivek C., Cho Ee Ng, Christopher J. Black, and Alexander C. Ford. “Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome. Authors' reply.” Aliment Pharmacol Ther 56, no. 5 (September 2022): 894–95. https://doi.org/10.1111/apt.17160.Full Text Link to Item
-
Ingrosso, Maria Rosa, Gianluca Ianiro, Judy Nee, Anthony J. Lembo, Paul Moayyedi, Christopher J. Black, and Alexander C. Ford. “Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome.” Aliment Pharmacol Ther 56, no. 6 (September 2022): 932–41. https://doi.org/10.1111/apt.17179.Full Text Link to Item
-
Eusebi, Leonardo H., Andrea Telese, Giovanna G. Cirota, Rehan Haidry, R Maurizio Zagari, Franco Bazzoli, and Alexander C. Ford. “Effect of gastro-esophageal reflux symptoms on the risk of Barrett's esophagus: A systematic review and meta-analysis.” J Gastroenterol Hepatol 37, no. 8 (August 2022): 1507–16. https://doi.org/10.1111/jgh.15902.Full Text Link to Item
-
Alderson, Sarah L., Alexandra Wright-Hughes, Alexander C. Ford, Amanda Farrin, Suzanne Hartley, Catherine Fernandez, Christopher Taylor, et al. “Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary care.” Trials 23, no. 1 (July 8, 2022): 552. https://doi.org/10.1186/s13063-022-06492-6.Full Text Link to Item
-
Fairbrass, Keeley M., David J. Gracie, and Alexander C. Ford. “Relative Contribution of Disease Activity and Psychological Health to Prognosis of Inflammatory Bowel Disease During 6.5 Years of Longitudinal Follow-Up.” Gastroenterology 163, no. 1 (July 2022): 190-203.e5. https://doi.org/10.1053/j.gastro.2022.03.014.Full Text Link to Item
-
Goodoory, Vivek C., Cho Ee Ng, Christopher J. Black, and Alexander C. Ford. “Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom.” Aliment Pharmacol Ther 56, no. 1 (July 2022): 110–20. https://doi.org/10.1111/apt.16939.Full Text Link to Item
-
Savarino, Edoardo, Fabiana Zingone, Brigida Barberio, Giovanni Marasco, Filiz Akyuz, Hale Akpinar, Oana Barboi, et al. “Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility.” United European Gastroenterol J 10, no. 6 (July 2022): 556–84. https://doi.org/10.1002/ueg2.12259.Full Text Link to Item
-
Barberio, Brigida, Edoardo V. Savarino, Christopher J. Black, and Alexander C. Ford. “Adverse events in trials of licensed drugs for irritable bowel syndrome with constipation or diarrhea: Systematic review and meta-analysis.” Neurogastroenterol Motil 34, no. 6 (June 2022): e14279. https://doi.org/10.1111/nmo.14279.Full Text Link to Item
-
Black, Christopher J., Heidi M. Staudacher, and Alexander C. Ford. “Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis.” Gut 71, no. 6 (June 2022): 1117–26. https://doi.org/10.1136/gutjnl-2021-325214.Full Text Link to Item
-
Black, Christopher J., and Alexander C. Ford. “Letter in response to Black et al. (2020): Authors' Reply.” Neurogastroenterol Motil 34, no. 6 (June 2022): e14388. https://doi.org/10.1111/nmo.14388.Full Text Link to Item
-
Goodoory, Vivek C., Cho Ee Ng, Christopher J. Black, and Alexander C. Ford. “Editorial: estimating the costs of care in irritable bowel syndrome-a necessary step to enhance value-based care for a high-prevalence, low-cost condition. Authors' reply.” Aliment Pharmacol Ther 55, no. 12 (June 2022): 1590–91. https://doi.org/10.1111/apt.16966.Full Text Link to Item
-
Goodoory, Vivek C., Orla F. Craig, David J. Gracie, Christopher J. Black, and Alexander C. Ford. “Prognosis of patients with Rome IV-defined versus physician-diagnosed irritable bowel syndrome: Longitudinal follow-up study.” Neurogastroenterol Motil 34, no. 6 (June 2022): e14282. https://doi.org/10.1111/nmo.14282.Full Text Link to Item
-
Barberio, Brigida, Edoardo Vincenzo Savarino, Christopher J. Black, and Alexander C. Ford. “Placebo Response Rates in Trials of Licensed Drugs for Irritable Bowel Syndrome With Constipation or Diarrhea: Meta-analysis.” Clin Gastroenterol Hepatol 20, no. 5 (May 2022): e923–44. https://doi.org/10.1016/j.cgh.2021.08.025.Full Text Link to Item
-
Black, Christopher J., and Alexander C. Ford. “Assessing the Impact of Changes to the Rome IV Criteria for Clinical Practice in Irritable Bowel Syndrome.” Gastroenterology 162, no. 6 (May 2022): 1752-1754.e1. https://doi.org/10.1053/j.gastro.2022.01.021.Full Text Link to Item
-
Fairbrass, Keeley M., Christian P. Selinger, David J. Gracie, and Alexander C. Ford. “Prevalence and impact of Rome IV versus Rome III irritable bowel syndrome in patients with inflammatory bowel disease.” Neurogastroenterol Motil 34, no. 5 (May 2022): e14256. https://doi.org/10.1111/nmo.14256.Full Text Link to Item
-
Goodoory, Vivek C., Cho Ee Ng, Christopher J. Black, and Alexander C. Ford. “Willingness to accept risk with medication in return for cure of symptoms among patients with Rome IV irritable bowel syndrome.” Aliment Pharmacol Ther 55, no. 10 (May 2022): 1311–19. https://doi.org/10.1111/apt.16816.Full Text Link to Item
-
Goodoory, Vivek C., Cho Ee Ng, Christopher J. Black, and Alexander C. Ford. “Editorial: risky business. What do sufferers' perceptions of risk from interventions for IBS really mean? Authors' reply.” Aliment Pharmacol Ther 55, no. 9 (May 2022): 1220–21. https://doi.org/10.1111/apt.16917.Full Text Link to Item
-
Goodoory, Vivek C., Lesley A. Houghton, Christopher J. Black, and Alexander C. Ford. “Characteristics of, and natural history among, individuals with Rome IV functional bowel disorders.” Neurogastroenterol Motil 34, no. 5 (May 2022): e14268. https://doi.org/10.1111/nmo.14268.Full Text Link to Item
-
Christian, Robert A., Sarah T. Lander, Nicholas A. Bonazza, Emily K. Reinke, Trevor A. Lentz, Julie A. Dodds, Mary K. Mulcahey, Anne C. Ford, and Jocelyn R. Wittstein. “Venous Thromboembolism Prophylaxis and Hormonal Contraceptive Management Practice Patterns in the Perioperative Period for Anterior Cruciate Ligament Reconstruction.” Arthrosc Sports Med Rehabil 4, no. 2 (April 2022): e679–85. https://doi.org/10.1016/j.asmr.2021.12.010.Full Text Link to Item
-
Barberio, Brigida, Yan Yiannakou, Lesley A. Houghton, Christopher J. Black, Edoardo V. Savarino, and Alexander C. Ford. “Overlap of Rome IV Irritable Bowel Syndrome and Functional Dyspepsia and Effect on Natural History: A Longitudinal Follow-Up Study.” Clin Gastroenterol Hepatol 20, no. 2 (February 2022): e89–101. https://doi.org/10.1016/j.cgh.2021.04.011.Full Text Link to Item
-
Veettil, Sajesh K., Saranrat Sadoyu, Elizabeth M. Bald, Viji P. Chandran, Scott Anh Tuan Khuu, Panitan Pitak, Yeong Yeh Lee, et al. “Association of proton-pump inhibitor use with adverse health outcomes: A systematic umbrella review of meta-analyses of cohort studies and randomised controlled trials.” Br J Clin Pharmacol 88, no. 4 (February 2022): 1551–66. https://doi.org/10.1111/bcp.15103.Full Text Link to Item
-
Ford, Alexander C., Evangelos Tsipotis, Yuhong Yuan, Grigorios I. Leontiadis, and Paul Moayyedi. “Efficacy of Helicobacter pylori eradication therapy for functional dyspepsia: updated systematic review and meta-analysis.” Gut, January 12, 2022. https://doi.org/10.1136/gutjnl-2021-326583.Full Text Link to Item
-
Barberio, Brigida, Sonia Facchin, Ilaria Patuzzi, Alexander C. Ford, Davide Massimi, Giorgio Valle, Eleonora Sattin, et al. “A specific microbiota signature is associated to various degrees of ulcerative colitis as assessed by a machine learning approach.” Gut Microbes 14, no. 1 (2022): 2028366. https://doi.org/10.1080/19490976.2022.2028366.Full Text Link to Item
-
Winters, C., and A. C. Ford. “Immortal time bias in a retrospective study examining colorectal cancer mortality according to adherence to colonoscopy.” Gut, January 1, 2022. https://doi.org/10.1136/gutjnl-2022-328419.Full Text
-
Burr, Nicholas E., David J. Gracie, Christopher J. Black, and Alexander C. Ford. “Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis.” Gut, December 22, 2021. https://doi.org/10.1136/gutjnl-2021-326390.Full Text Link to Item
-
Barberio, Brigida, Davide Massimi, Nora Cazzagon, Fabiana Zingone, Alexander C. Ford, and Edoardo V. Savarino. “Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.” Gastroenterology 161, no. 6 (December 2021): 1865–77. https://doi.org/10.1053/j.gastro.2021.08.032.Full Text Link to Item
-
Keefer, Laurie, Cynthia W. Ko, and Alexander C. Ford. “AGA Clinical Practice Update on Management of Chronic Gastrointestinal Pain in Disorders of Gut-Brain Interaction: Expert Review.” Clin Gastroenterol Hepatol 19, no. 12 (December 2021): 2481-2488.e1. https://doi.org/10.1016/j.cgh.2021.07.006.Full Text Link to Item
-
Drossman, Douglas A., Lin Chang, Jill K. Deutsch, Alexander C. Ford, Albena Halpert, Kurt Kroenke, Samuel Nurko, Johannah Ruddy, Julie Snyder, and Ami Sperber. “A Review of the Evidence and Recommendations on Communication Skills and the Patient-Provider Relationship: A Rome Foundation Working Team Report.” Gastroenterology 161, no. 5 (November 2021): 1670-1688.e7. https://doi.org/10.1053/j.gastro.2021.07.037.Full Text Link to Item
-
Zamani, Mohammad, Shaghayegh Alizadeh-Tabari, Amir Hossein Hasanpour, Leonardo H. Eusebi, and Alexander C. Ford. “Systematic review with meta-analysis: association of Helicobacter pylori infection with gastro-oesophageal reflux and its complications.” Aliment Pharmacol Ther 54, no. 8 (October 2021): 988–98. https://doi.org/10.1111/apt.16585.Full Text Link to Item
-
Ferreira, Nuno, Antonina Mikocka-Walus, Miranda A. L. van Tilburg, Lesley A. Graff, Pragalathan Apputhurai, Manuel Barreiro-de Acosta, Floor Bennebroek Evertsz, et al. “The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study.” J Psychosom Res 148 (September 2021): 110561. https://doi.org/10.1016/j.jpsychores.2021.110561.Full Text Link to Item
-
Klaassen, Tim, Fabienne G. M. Smeets, Lisa Vork, Jan Tack, Nicholas J. Talley, Magnus Simrén, Qasim Aziz, et al. “Psychometric evaluation of an experience sampling method-based patient-reported outcome measure in functional dyspepsia.” Neurogastroenterol Motil 33, no. 9 (September 2021): e14136. https://doi.org/10.1111/nmo.14136.Full Text Link to Item
-
Barberio, Brigida, Ciaran Judge, Edoardo V. Savarino, and Alexander C. Ford. “Global prevalence of functional constipation according to the Rome criteria: a systematic review and meta-analysis.” Lancet Gastroenterol Hepatol 6, no. 8 (August 2021): 638–48. https://doi.org/10.1016/S2468-1253(21)00111-4.Full Text Link to Item
-
Fairbrass, Keeley M., David J. Gracie, and Alexander C. Ford. “Longitudinal follow-up study: effect of psychological co-morbidity on the prognosis of inflammatory bowel disease.” Aliment Pharmacol Ther 54, no. 4 (August 2021): 441–50. https://doi.org/10.1111/apt.16454.Full Text Link to Item
-
Tasson, Laura, Fabiana Zingone, Brigida Barberio, Romina Valentini, Pamela Ballotta, Alexander C. Ford, Marco Scarpa, Imerio Angriman, Matteo Fassan, and Edoardo Savarino. “Sarcopenia, severe anxiety and increased C-reactive protein are associated with severe fatigue in patients with inflammatory bowel diseases.” Sci Rep 11, no. 1 (July 27, 2021): 15251. https://doi.org/10.1038/s41598-021-94685-5.Full Text Link to Item
-
Barberio, Brigida, Jonathan P. Segal, M Nabil Quraishi, Christopher J. Black, Edoardo V. Savarino, and Alexander C. Ford. “Efficacy of Oral, Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Network Meta-analysis.” J Crohns Colitis 15, no. 7 (July 5, 2021): 1184–96. https://doi.org/10.1093/ecco-jcc/jjab010.Full Text Link to Item
-
Corsetti, Maura, Steven Brown, Giuseppe Chiarioni, Eirini Dimidi, Thomas Dudding, Anton Emmanuel, Mark Fox, et al. “Chronic constipation in adults: Contemporary perspectives and clinical challenges. 2: Conservative, behavioural, medical and surgical treatment.” Neurogastroenterol Motil 33, no. 7 (July 2021): e14070. https://doi.org/10.1111/nmo.14070.Full Text Link to Item
-
Nelson, Alfred D., Christopher J. Black, Lesley A. Houghton, Nahyr Sofía Lugo-Fagundo, Brian E. Lacy, and Alexander C. Ford. “Editorial: recognising the efficacy of licensed drug therapies for irritable bowel syndrome on bloating-a step in the right direction for targeted treatment? Authors' reply.” Aliment Pharmacol Ther 54, no. 2 (July 2021): 198–99. https://doi.org/10.1111/apt.16443.Full Text Link to Item
-
Nelson, Alfred D., Christopher J. Black, Lesley A. Houghton, Nahyr Sofía Lugo-Fagundo, Brian E. Lacy, and Alexander C. Ford. “Systematic review and network meta-analysis: efficacy of licensed drugs for abdominal bloating in irritable bowel syndrome with constipation.” Aliment Pharmacol Ther 54, no. 2 (July 2021): 98–108. https://doi.org/10.1111/apt.16437.Full Text Link to Item
-
Vasant, Dipesh H., Peter A. Paine, Christopher J. Black, Lesley A. Houghton, Hazel A. Everitt, Maura Corsetti, Anurag Agrawal, et al. “British Society of Gastroenterology guidelines on the management of irritable bowel syndrome.” Gut 70, no. 7 (July 2021): 1214–40. https://doi.org/10.1136/gutjnl-2021-324598.Full Text Link to Item
-
Bosire, Claire, Adriana C. Vidal, Jennifer S. Smith, Dereje Jima, Zhiqing Huang, David Skaar, Fidel Valea, et al. “Association between PEG3 DNA methylation and high-grade cervical intraepithelial neoplasia.” Infect Agent Cancer 16, no. 1 (June 13, 2021): 42. https://doi.org/10.1186/s13027-021-00382-3.Full Text Link to Item
-
Black, Christopher J., Orla Craig, David J. Gracie, and Alexander C. Ford. “Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.” Gut 70, no. 6 (June 2021): 1110–16. https://doi.org/10.1136/gutjnl-2020-322519.Full Text Link to Item
-
Black, Christopher J., and Alexander C. Ford. “Irritable bowel syndrome: a spotlight on future research needs.” Lancet Gastroenterol Hepatol 6, no. 6 (June 2021): 419–22. https://doi.org/10.1016/S2468-1253(21)00131-X.Full Text Link to Item
-
Fairbrass, Keeley M., David J. Gracie, and Alexander C. Ford. “Healthy Mind, Healthy Body: Chronic Depression May Predate the Development of Inflammatory Bowel Disease by up to 9 Years.” Gastroenterology 160, no. 7 (June 2021): 2611–13. https://doi.org/10.1053/j.gastro.2021.02.004.Full Text Link to Item
-
Goodoory, Vivek C., Christopher J. Black, and Alexander C. Ford. “Efficacy of Senna and Magnesium Oxide for the Treatment of Chronic Idiopathic Constipation.” Am J Gastroenterol 116, no. 6 (June 1, 2021): 1352–53. https://doi.org/10.14309/ajg.0000000000001041.Full Text Link to Item
-
Scott, S Mark, Magnus Simrén, Adam D. Farmer, Philip G. Dinning, Emma V. Carrington, Marc A. Benninga, Rebecca E. Burgell, et al. “Chronic constipation in adults: Contemporary perspectives and clinical challenges. 1: Epidemiology, diagnosis, clinical associations, pathophysiology and investigation.” Neurogastroenterol Motil 33, no. 6 (June 2021): e14050. https://doi.org/10.1111/nmo.14050.Full Text Link to Item
-
Barberio, Brigida, Christopher J. Black, Edoardo V. Savarino, and Alexander C. Ford. “Ciclosporin or Infliximab as Rescue Therapy in Acute Glucorticosteroid-Refractory Ulcerative Colitis: Systematic Review and Network Meta-Analysis.” J Crohns Colitis 15, no. 5 (May 4, 2021): 733–41. https://doi.org/10.1093/ecco-jcc/jjaa226.Full Text Link to Item
-
Barberio, Brigida, Mohammad Zamani, Christopher J. Black, Edoardo V. Savarino, and Alexander C. Ford. “Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis.” Lancet Gastroenterol Hepatol 6, no. 5 (May 2021): 359–70. https://doi.org/10.1016/S2468-1253(21)00014-5.Full Text Link to Item
-
Black, Christopher J., Yan Yiannakou, Elspeth Guthrie, Robert West, Lesley A. Houghton, and Alexander C. Ford. “Longitudinal follow-up of a novel classification system for irritable bowel syndrome: natural history and prognostic value.” Aliment Pharmacol Ther 53, no. 10 (May 2021): 1126–37. https://doi.org/10.1111/apt.16322.Full Text Link to Item
-
Black, Christopher J., and Alexander C. Ford. “Editorial: co-morbid gastrointestinal conditions are an important consideration in IBS management-authors' reply.” Aliment Pharmacol Ther 53, no. 10 (May 2021): 1153–54. https://doi.org/10.1111/apt.16351.Full Text Link to Item
-
Eusebi, Leonardo H., Andrea Telese, Giovanna G. Cirota, Rehan Haidry, Rocco M. Zagari, Franco Bazzoli, and Alexander C. Ford. “Systematic review with meta-analysis: risk factors for Barrett's oesophagus in individuals with gastro-oesophageal reflux symptoms.” Aliment Pharmacol Ther 53, no. 9 (May 2021): 968–76. https://doi.org/10.1111/apt.16321.Full Text Link to Item
-
Staudacher, Heidi M., Antonina Mikocka-Walus, and Alexander C. Ford. “Common mental disorders in irritable bowel syndrome: pathophysiology, management, and considerations for future randomised controlled trials.” Lancet Gastroenterol Hepatol 6, no. 5 (May 2021): 401–10. https://doi.org/10.1016/S2468-1253(20)30363-0.Full Text Link to Item
-
Black, Christopher J., and Alexander C. Ford. “Biochemical Tests for Bile Acid Diarrhea: Real-World Studies Required.” Am J Gastroenterol 116, no. 4 (April 2021): 833–34. https://doi.org/10.14309/ajg.0000000000000976.Full Text Link to Item
-
Ye, Yizhou, Baoguo Jiang, Sudhakar Manne, Peter L. Moses, Cristina Almansa, Dimitri Bennett, Paul Dolin, and Alexander C. Ford. “Epidemiology and outcomes of gastroparesis, as documented in general practice records, in the United Kingdom.” Gut 70, no. 4 (April 2021): 644–53. https://doi.org/10.1136/gutjnl-2020-321277.Full Text Link to Item
-
Carbone, M Florencia, Sanjiv Mahadeva, Brian E. Lacy, Nicholas J. Talley, and Alexander C. Ford. “Satiation or satiety? More than mere semantics - Authors' reply.” Lancet 397, no. 10279 (March 20, 2021): 1061. https://doi.org/10.1016/S0140-6736(21)00239-7.Full Text Link to Item
-
Barberio, Brigida, Christopher J. Black, and Alexander C. Ford. “Editorial: will clusters for anxiety, depression, sleep disturbance and fatigue symptoms predict treatment outcomes in functional dyspepsia? Authors' reply.” Aliment Pharmacol Ther 53, no. 5 (March 2021): 652–53. https://doi.org/10.1111/apt.16247.Full Text Link to Item
-
Eusebi, Leonardo Henry, Giovanna Grazia Cirota, Rocco Maurizio Zagari, and Alexander Charles Ford. “Global prevalence of Barrett's oesophagus and oesophageal cancer in individuals with gastro-oesophageal reflux: a systematic review and meta-analysis.” Gut 70, no. 3 (March 2021): 456–63. https://doi.org/10.1136/gutjnl-2020-321365.Full Text Link to Item
-
Black, Christopher J., and Alexander C. Ford. “Efficacy of Ondansetron for Irritable Bowel Syndrome With Diarrhea.” Am J Gastroenterol 116, no. 2 (February 1, 2021): 428–29. https://doi.org/10.14309/ajg.0000000000000932.Full Text Link to Item
-
Barberio, Brigida, Maria Ines Pinto-Sanchez, Premysl Bercik, Ruchit Sood, Edoardo V. Savarino, Paul Moayyedi, Christopher J. Black, and Alexander C. Ford. “Derivation and validation of a novel method to subgroup patients with functional dyspepsia: beyond upper gastrointestinal symptoms.” Aliment Pharmacol Ther 53, no. 2 (January 2021): 253–64. https://doi.org/10.1111/apt.16184.Full Text Link to Item
-
Black, Christopher J., and Alexander Charles Ford. “Best management of irritable bowel syndrome.” Frontline Gastroenterol 12, no. 4 (2021): 303–15. https://doi.org/10.1136/flgastro-2019-101298.Full Text Link to Item
-
Fairbrass, Keeley M., Deloar Hoshen, David J. Gracie, and Alexander C. Ford. “Effect of ACE inhibitors and angiotensin II receptor blockers on disease outcomes in inflammatory bowel disease.” Gut 70, no. 1 (January 2021): 218–19. https://doi.org/10.1136/gutjnl-2020-321186.Full Text Link to Item
-
Ford, Alexander C., Paul Moayyedi, Christopher J. Black, Yuhong Yuan, Sajesh K. Veettil, Sanjiv Mahadeva, Kirati Kengkla, Nathorn Chaiyakunapruk, and Yeong Yeh Lee. “Systematic review and network meta-analysis: efficacy of drugs for functional dyspepsia.” Aliment Pharmacol Ther 53, no. 1 (January 2021): 8–21. https://doi.org/10.1111/apt.16072.Full Text Link to Item
-
Mundre, Pradeep, Christopher J. Black, Noor Mohammed, and Alexander C. Ford. “Efficacy of surgical or endoscopic treatment of idiopathic achalasia: a systematic review and network meta-analysis.” Lancet Gastroenterol Hepatol 6, no. 1 (January 2021): 30–38. https://doi.org/10.1016/S2468-1253(20)30296-X.Full Text Link to Item
-
Selinger, Christian, Jenelyn Carbonell, John Kane, Mandour Omer, and Alexander Charles Ford. “Acceptability of a 'treat to target' approach in inflammatory bowel disease to patients in clinical remission.” Frontline Gastroenterol 12, no. 1 (2021): 30–38. https://doi.org/10.1136/flgastro-2019-101366.Full Text Link to Item
-
Black, Christopher J., and Alexander C. Ford. “How effective are antibiotics for the treatment of irritable bowel syndrome?” Expert Opin Pharmacother 21, no. 18 (December 2020): 2195–97. https://doi.org/10.1080/14656566.2020.1808623.Full Text Link to Item
-
Fairbrass, Keeley M., Sarah J. Costantino, David J. Gracie, and Alexander C. Ford. “Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis.” Lancet Gastroenterol Hepatol 5, no. 12 (December 2020): 1053–62. https://doi.org/10.1016/S2468-1253(20)30300-9.Full Text Link to Item
-
Ford, Alexander Charles, Yuhong Yuan, and Paul Moayyedi. “Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis.” Gut 69, no. 12 (December 2020): 2113–21. https://doi.org/10.1136/gutjnl-2020-320839.Full Text Link to Item
-
Ford, Alexander C., Ami D. Sperber, Maura Corsetti, and Michael Camilleri. “Irritable bowel syndrome.” Lancet 396, no. 10263 (November 21, 2020): 1675–88. https://doi.org/10.1016/S0140-6736(20)31548-8.Full Text Link to Item
-
Ford, Alexander C., Sanjiv Mahadeva, M Florencia Carbone, Brian E. Lacy, and Nicholas J. Talley. “Functional dyspepsia.” Lancet 396, no. 10263 (November 21, 2020): 1689–1702. https://doi.org/10.1016/S0140-6736(20)30469-4.Full Text Link to Item
-
Black, Christopher J., and Alexander C. Ford. “Faecal incontinence is not rare in irritable bowel syndrome.” Frontline Gastroenterol 11, no. 6 (October 2020): 494–96. https://doi.org/10.1136/flgastro-2020-101518.Full Text Link to Item
-
Oka, Priya, Heather Parr, Brigida Barberio, Christopher J. Black, Edoardo V. Savarino, and Alexander C. Ford. “Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis.” Lancet Gastroenterol Hepatol 5, no. 10 (October 2020): 908–17. https://doi.org/10.1016/S2468-1253(20)30217-X.Full Text Link to Item
-
Barberio, Brigida, Sanjiv Mahadeva, Christopher J. Black, Edoardo V. Savarino, and Alexander C. Ford. “Systematic review with meta-analysis: global prevalence of uninvestigated dyspepsia according to the Rome criteria.” Aliment Pharmacol Ther 52, no. 5 (September 2020): 762–73. https://doi.org/10.1111/apt.16006.Full Text Link to Item
-
Ianiro, Gianluca, Serena Porcari, Alexander Charles Ford, Antonio Gasbarrini, and Giovanni Cammarota. “Letter: faecal microbiota transplantation for irritable bowel syndrome-room for improvement.” Aliment Pharmacol Ther 52, no. 5 (September 2020): 923–24. https://doi.org/10.1111/apt.15923.Full Text Link to Item
-
Black, Christopher J., Brigida Barberio, and Alexander C. Ford. “Editorial: minesapride for irritable bowel syndrome with constipation.” Aliment Pharmacol Ther 52, no. 4 (August 2020): 713–14. https://doi.org/10.1111/apt.15941.Full Text Link to Item
-
Black, Christopher J., Elyse R. Thakur, Lesley A. Houghton, Eamonn M. M. Quigley, Paul Moayyedi, and Alexander C. Ford. “Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis.” Gut 69, no. 8 (August 2020): 1441–51. https://doi.org/10.1136/gutjnl-2020-321191.Full Text Link to Item
-
Black, Christopher J., Yan Yiannakou, Lesley A. Houghton, Farag Shuweihdi, Robert West, Elspeth Guthrie, and Alexander C. Ford. “Anxiety-related factors associated with symptom severity in irritable bowel syndrome.” Neurogastroenterol Motil 32, no. 8 (August 2020): e13872. https://doi.org/10.1111/nmo.13872.Full Text Link to Item
-
Black, Christopher J., and Alexander C. Ford. “Global burden of irritable bowel syndrome: trends, predictions and risk factors.” Nat Rev Gastroenterol Hepatol 17, no. 8 (August 2020): 473–86. https://doi.org/10.1038/s41575-020-0286-8.Full Text Link to Item
-
Vasant, Dipesh H., and Alexander C. Ford. “Functional gastrointestinal disorders in inflammatory bowel disease: Time for a paradigm shift?” World J Gastroenterol 26, no. 26 (July 14, 2020): 3712–19. https://doi.org/10.3748/wjg.v26.i26.3712.Full Text Link to Item
-
Black, Christopher J., Paul Moayyedi, Eamonn M. M. Quigley, and Alexander C. Ford. “Peppermint Oil in Irritable Bowel Syndrome.” Gastroenterology 159, no. 1 (July 2020): 395–96. https://doi.org/10.1053/j.gastro.2019.09.055.Full Text Link to Item
-
Black, Christopher J., and Alexander C. Ford. “Use of Lactulose Breath Tests to Predict Response to Rifaximin in Irritable Bowel Syndrome With Diarrhea: The Positives and Negatives.” Am J Gastroenterol 115, no. 6 (June 2020): 955–56. https://doi.org/10.14309/ajg.0000000000000569.Full Text Link to Item
-
Black, Christopher J., Nicholas E. Burr, and Alexander C. Ford. “Relative Efficacy of Tegaserod in a Systematic Review and Network Meta-analysis of Licensed Therapies for Irritable Bowel Syndrome With Constipation.” Clin Gastroenterol Hepatol 18, no. 5 (May 2020): 1238-1239.e1. https://doi.org/10.1016/j.cgh.2019.07.007.Full Text Link to Item
-
Black, Christopher J., and Alexander C. Ford. “Predicting Response to Rifaximin in Irritable Bowel Syndrome with Diarrhea: Is the Answer Blowing in the Wind?” Gastroenterology 158, no. 5 (April 2020): 1508–10. https://doi.org/10.1053/j.gastro.2020.02.018.Full Text Link to Item
-
O’Connor, Anthony, David J. Gracie, P John Hamlin, and Alexander C. Ford. “Predictors of Dyspareunia Among Female Patients With Inflammatory Bowel Disease.” Clin Gastroenterol Hepatol 18, no. 4 (April 2020): 1000–1001. https://doi.org/10.1016/j.cgh.2019.07.065.Full Text Link to Item
-
Black, Christopher J., Lesley A. Houghton, and Alexander C. Ford. “Efficacy of Eluxadoline in Irritable Bowel Syndrome With Diarrhea.” Am J Gastroenterol 115, no. 3 (March 2020): 483–84. https://doi.org/10.14309/ajg.0000000000000518.Full Text Link to Item
-
Black, Christopher J., and Alexander C. Ford. “Rational investigations in irritable bowel syndrome.” Frontline Gastroenterol 11, no. 2 (March 2020): 140–47. https://doi.org/10.1136/flgastro-2019-101211.Full Text Link to Item
-
Mikocka-Walus, Antonina, Alexander C. Ford, and Douglas A. Drossman. “Antidepressants in inflammatory bowel disease.” Nat Rev Gastroenterol Hepatol 17, no. 3 (March 2020): 184–92. https://doi.org/10.1038/s41575-019-0259-y.Full Text Link to Item
-
Black, Christopher J., Yuhong Yuan, Christian P. Selinger, Michael Camilleri, Eamonn M. M. Quigley, Paul Moayyedi, and Alexander C. Ford. “Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis.” Lancet Gastroenterol Hepatol 5, no. 2 (February 2020): 117–31. https://doi.org/10.1016/S2468-1253(19)30324-3.Full Text Link to Item
-
Harris, Benjamin S., Katherine C. Bishop, Jeffrey A. Kuller, Anne C. Ford, Lisa C. Muasher, Sarah E. Cantrell, and Thomas M. Price. “Hormonal management of menopausal symptoms in women with a history of gynecologic malignancy.” Menopause 27, no. 2 (February 2020): 243–48. https://doi.org/10.1097/GME.0000000000001447.Full Text Open Access Copy Link to Item
-
Black, Christopher J., Nicholas E. Burr, Michael Camilleri, David L. Earnest, Eamonn Mm Quigley, Paul Moayyedi, Lesley A. Houghton, and Alexander C. Ford. “Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis.” Gut 69, no. 1 (January 2020): 74–82. https://doi.org/10.1136/gutjnl-2018-318160.Full Text Link to Item
-
Ford, Alexander C. “Commentary: estimating the prevalence of IBS globally-past, present and future.” Aliment Pharmacol Ther 51, no. 1 (January 2020): 198–99. https://doi.org/10.1111/apt.15508.Full Text Link to Item
-
Eusebi, Leonardo H., Christopher J. Black, Colin W. Howden, and Alexander C. Ford. “Effectiveness of management strategies for uninvestigated dyspepsia: systematic review and network meta-analysis.” Bmj 367 (December 11, 2019): l6483. https://doi.org/10.1136/bmj.l6483.Full Text Link to Item
-
Ianiro, Gianluca, Rita Murri, Giusi Desirè Sciumè, Michele Impagnatiello, Luca Masucci, Alexander C. Ford, Graham R. Law, et al. “Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study.” Ann Intern Med 171, no. 10 (November 19, 2019): 695–702. https://doi.org/10.7326/M18-3635.Full Text Link to Item
-
Luthra, Pavit, Michael Camilleri, Nicholas E. Burr, Eamonn M. M. Quigley, Christopher J. Black, and Alexander C. Ford. “Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis.” Lancet Gastroenterol Hepatol 4, no. 11 (November 2019): 831–44. https://doi.org/10.1016/S2468-1253(19)30246-8.Full Text Link to Item
-
Black, Christopher J., Alexander C. Ford, and Lesley A. Houghton. “Editorial: understanding differences in patient response to ondansetron in irritable bowel syndrome with diarrhoea-are we any closer?” Aliment Pharmacol Ther 50, no. 7 (October 2019): 825–26. https://doi.org/10.1111/apt.15455.Full Text Link to Item
-
Ford, Alexander Charles, and Peter R. Gibson. “Efficacy of glutamine in postinfection IBS.” Gut 68, no. 10 (October 2019): 1905–6. https://doi.org/10.1136/gutjnl-2018-317438.Full Text Link to Item
-
Luthra, Pavit, Nicholas E. Burr, and Alexander C. Ford. “Relative Efficacy of Naloxegol and Polyethylene Glycol 3350 in Opioid-Induced Constipation.” Am J Gastroenterol 114, no. 10 (October 2019): 1694. https://doi.org/10.14309/ajg.0000000000000308.Full Text Link to Item
-
Lim, Shujing Jane, David J. Gracie, John S. Kane, Saqib Mumtaz, Andrew F. Scarsbrook, Fahmid U. Chowdhury, Alexander C. Ford, and Christopher J. Black. “Prevalence of, and predictors of, bile acid diarrhea in outpatients with chronic diarrhea: A follow-up study.” Neurogastroenterol Motil 31, no. 9 (September 2019): e13666. https://doi.org/10.1111/nmo.13666.Full Text Link to Item
-
Burr, Nicholas E., and Alexander C. Ford. “Assessing the efficacy of peripherally acting µ-opioid receptor antagonists (PAMORAs) in the treatment of opioid-induced constipation: authors reply.” Gut 68, no. 8 (August 2019): 1530–31. https://doi.org/10.1136/gutjnl-2018-316977.Full Text Link to Item
-
Gracie, David J., P John Hamlin, and Alexander C. Ford. “The influence of the brain-gut axis in inflammatory bowel disease and possible implications for treatment.” Lancet Gastroenterol Hepatol 4, no. 8 (August 2019): 632–42. https://doi.org/10.1016/S2468-1253(19)30089-5.Full Text Link to Item
-
Ianiro, Gianluca, Leonardo H. Eusebi, Christopher J. Black, Antonio Gasbarrini, Giovanni Cammarota, and Alexander C. Ford. “Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome.” Aliment Pharmacol Ther 50, no. 3 (August 2019): 240–48. https://doi.org/10.1111/apt.15330.Full Text Link to Item
-
Narula, Neeraj, Maria Ines Pinto-Sanchez, Natalia Causada Calo, Alexander C. Ford, Premsyl Bercik, Walter Reinisch, and Paul Moayyedi. “Response to Letter by Moulton et al.” Inflamm Bowel Dis 25, no. 8 (July 17, 2019): e99. https://doi.org/10.1093/ibd/izz035.Full Text Link to Item
-
Choy, Matthew C., Dean Seah, David M. Faleck, Shailja C. Shah, Che-Yung Chao, Yoon-Kyo An, Graham Radford-Smith, et al. “Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis.” Inflamm Bowel Dis 25, no. 7 (June 18, 2019): 1169–86. https://doi.org/10.1093/ibd/izy383.Full Text Link to Item
-
Narula, Neeraj, Maria Ines Pinto-Sanchez, Natalia Causada Calo, Alexander C. Ford, Premsyl Bercik, Walter Reinisch, and Paul Moayyedi. “Anxiety But Not Depression Predicts Poor Outcomes in Inflammatory Bowel Disease.” Inflamm Bowel Dis 25, no. 7 (June 18, 2019): 1255–61. https://doi.org/10.1093/ibd/izy385.Full Text Link to Item
-
Burr, Nicholas E., Barry Hall, P John Hamlin, Christian P. Selinger, Alexander C. Ford, and Anthony O’Connor. “Systematic Review and Network Meta-Analysis of Medical Therapies to Prevent Recurrence of Post-Operative Crohn's Disease.” J Crohns Colitis 13, no. 6 (May 27, 2019): 693–701. https://doi.org/10.1093/ecco-jcc/jjy216.Full Text Link to Item
-
Ford, Alexander C., Lucinda A. Harris, Brian E. Lacy, Eamonn M. M. Quigley, and Paul Moayyedi. “Letter: meta-analysis of prebiotics, probiotics, synbiotics and antibiotics in IBS. Authors' reply.” Aliment Pharmacol Ther 49, no. 9 (May 2019): 1254–55. https://doi.org/10.1111/apt.15234.Full Text Link to Item
-
Bishop, Katherine C., Anne C. Ford, Jeffrey A. Kuller, and Sarah Dotters-Katz. “Acupuncture in Obstetrics and Gynecology.” Obstet Gynecol Surv 74, no. 4 (April 2019): 241–51. https://doi.org/10.1097/OGX.0000000000000655.Full Text Link to Item
-
Luthra, Pavit, Nicholas E. Burr, Darren M. Brenner, and Alexander C. Ford. “Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and network meta-analysis.” Gut 68, no. 3 (March 2019): 434–44. https://doi.org/10.1136/gutjnl-2018-316001.Full Text Link to Item
-
Gracie, David J., and Alexander C. Ford. “Functional Gastrointestinal Symptoms in Inflammatory Bowel Disease: Rising to the Challenge.” Clin Gastroenterol Hepatol 17, no. 3 (February 2019): 572–73. https://doi.org/10.1016/j.cgh.2018.08.039.Full Text Link to Item
-
Smeets, Fabiënne G. M., Daniel Keszthelyi, Lisa Vork, Jan Tack, Nicholas J. Talley, Magnus Simren, Qasim Aziz, et al. “Development of a real-time patient-reported outcome measure for symptom assessment in patients with functional dyspepsia using the experience sampling method.” Neurogastroenterol Motil 31, no. 2 (February 2019): e13496. https://doi.org/10.1111/nmo.13496.Full Text Link to Item
-
Ford, Alexander C., Brian E. Lacy, Lucinda A. Harris, Eamonn M. M. Quigley, and Paul Moayyedi. “Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis.” Am J Gastroenterol 114, no. 1 (January 2019): 21–39. https://doi.org/10.1038/s41395-018-0222-5.Full Text Link to Item
-
O’Connor, Anthony, Raguprakash Ratnakumaran, Lisa Warren, Debbie Pullen, Anna Errington, David J. Gracie, Rebecca C. Sagar, P John Hamlin, and Alexander C. Ford. “Randomized controlled trial: a pilot study of a psychoeducational intervention for fatigue in patients with quiescent inflammatory bowel disease.” Ther Adv Chronic Dis 10 (2019): 2040622319838439. https://doi.org/10.1177/2040622319838439.Full Text Link to Item
-
Wu, Irene X. Y., Charlene H. L. Wong, Robin S. T. Ho, William K. W. Cheung, Alexander C. Ford, Justin C. Y. Wu, Arthur D. P. Mak, Holger Cramer, and Vincent C. H. Chung. “Acupuncture and related therapies for treating irritable bowel syndrome: overview of systematic reviews and network meta-analysis.” Therap Adv Gastroenterol 12 (2019): 1756284818820438. https://doi.org/10.1177/1756284818820438.Full Text Link to Item
-
Black, Christopher J., Nicholas E. Burr, Eamonn M. M. Quigley, Paul Moayyedi, Lesley A. Houghton, and Alexander C. Ford. “Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis.” Gastroenterology 155, no. 6 (December 2018): 1753–63. https://doi.org/10.1053/j.gastro.2018.08.021.Full Text Link to Item
-
Black, Christopher J., and Alexander C. Ford. “Probiotics for Treating Irritable Bowel Syndrome: Are Bugs the Best Drugs?” Gastroenterology 155, no. 6 (December 2018): 2019–21. https://doi.org/10.1053/j.gastro.2018.11.015.Full Text Link to Item
-
Cheong, Pui Kuan, Alexander C. Ford, Cynthia K. Y. Cheung, Jessica Y. L. Ching, Yawen Chan, Joseph J. Y. Sung, Francis K. L. Chan, and Justin C. Y. Wu. “Low-dose imipramine for refractory functional dyspepsia: a randomised, double-blind, placebo-controlled trial.” Lancet Gastroenterol Hepatol 3, no. 12 (December 2018): 837–44. https://doi.org/10.1016/S2468-1253(18)30303-0.Full Text Link to Item
-
Ford, Alexander C. “Intending to Treat Patients With Irritable Bowel Syndrome With Cognitive-Behavioral Therapy.” Gastroenterology 155, no. 6 (December 2018): 2024. https://doi.org/10.1053/j.gastro.2018.05.054.Full Text Link to Item
-
Camilleri, Michael, Victor Chedid, Alexander C. Ford, Ken Haruma, Michael Horowitz, Karen L. Jones, Phillip A. Low, Seon-Young Park, Henry P. Parkman, and Vincenzo Stanghellini. “Gastroparesis.” Nat Rev Dis Primers 4, no. 1 (November 1, 2018): 41. https://doi.org/10.1038/s41572-018-0038-z.Full Text Link to Item
-
Ford, Alexander C., Lucinda A. Harris, Brian E. Lacy, Eamonn M. M. Quigley, and Paul Moayyedi. “Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome.” Aliment Pharmacol Ther 48, no. 10 (November 2018): 1044–60. https://doi.org/10.1111/apt.15001.Full Text Link to Item
-
Gracie, David J., and Alexander C. Ford. “Reply.” Gastroenterology 155, no. 5 (November 2018): 1652–53. https://doi.org/10.1053/j.gastro.2018.10.022.Full Text Link to Item
-
Dionne, Joanna, Alexander C. Ford, Yuhong Yuan, William D. Chey, Brian E. Lacy, Yuri A. Saito, Eamonn M. M. Quigley, and Paul Moayyedi. “A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome.” Am J Gastroenterol 113, no. 9 (September 2018): 1290–1300. https://doi.org/10.1038/s41395-018-0195-4.Full Text Link to Item
-
Rej, Anupam, Amanda Avery, Alexander Charles Ford, Anne Holdoway, Matthew Kurien, Yvonne McKenzie, Julie Thompson, et al. “Clinical application of dietary therapies in irritable bowel syndrome.” J Gastrointestin Liver Dis 27, no. 3 (September 2018): 307–16. https://doi.org/10.15403/jgld.2014.1121.273.avy.Full Text Link to Item
-
Ford, Alexander C. “Utility of the Oral Capsaicin Test in Diagnosing Functional Dyspepsia.” Am J Gastroenterol 113, no. 8 (August 2018): 1257–58. https://doi.org/10.1038/s41395-018-0113-9.Full Text Link to Item
-
Black, Christopher J., and Alexander C. Ford. “Chronic idiopathic constipation in adults: epidemiology, pathophysiology, diagnosis and clinical management.” Med J Aust 209, no. 2 (July 16, 2018): 86–91. https://doi.org/10.5694/mja18.00241.Full Text Link to Item
-
Ratnakumaran, Raguprakash, Lisa Warren, David J. Gracie, Rebecca C. Sagar, P John Hamlin, Anthony O’Connor, and Alexander C. Ford. “Fatigue in Inflammatory Bowel Disease Reflects Mood and Symptom-Reporting Behavior Rather Than Biochemical Activity or Anemia.” Clin Gastroenterol Hepatol 16, no. 7 (July 2018): 1165–67. https://doi.org/10.1016/j.cgh.2017.11.030.Full Text Link to Item
-
Shutkever, Oliver, David J. Gracie, Caroline Young, Henry M. Wood, Morag Taylor, P. John Hamlin, Alexander C. Ford, and Philip Quirke. “No Significant Association Between the Fecal Microbiome and the Presence of Irritable Bowel Syndrome-type Symptoms in Patients with Quiescent Inflammatory Bowel Disease.” Inflamm Bowel Dis 24, no. 7 (June 8, 2018): 1597–1605. https://doi.org/10.1093/ibd/izy052.Full Text Link to Item
-
Eusebi, Leonardo H., and Alexander C. Ford. “Young GI angle: How to approach evidence-based medicine.” United European Gastroenterol J 6, no. 5 (June 2018): 794–95. https://doi.org/10.1177/2050640618778442.Full Text Link to Item
-
Ford, Alexander C., Paul Moayyedi, William D. Chey, Lucinda A. Harris, Brian E. Lacy, Yuri A. Saito, Eamonn M. M. Quigley, and Eamonn M. M. ACG Task Force on Management of Irritable Bowel Syndrome. “American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome.” Am J Gastroenterol 113, no. Suppl 2 (June 2018): 1–18. https://doi.org/10.1038/s41395-018-0084-x.Full Text Link to Item
-
Leontiadis, Grigorios I., Alexander C. Ford, and Colin W. Howden. “Proton pump inhibitors and oesophageal cancer: Flawed methodology and false alarms.” Cancer Epidemiol 54 (June 2018): 137–38. https://doi.org/10.1016/j.canep.2018.04.002.Full Text Link to Item
-
Ratnakumaran, Raguprakash, Natalie To, David J. Gracie, Christian P. Selinger, Anthony O’Connor, Tanya Clark, Nicola Carey, et al. “Efficacy and tolerability of initiating, or switching to, infliximab biosimilar CT-P13 in inflammatory bowel disease (IBD): a large single-centre experience.” Scand J Gastroenterol 53, no. 6 (June 2018): 700–707. https://doi.org/10.1080/00365521.2018.1464203.Full Text Link to Item
-
Gracie, David J., Elspeth A. Guthrie, P John Hamlin, and Alexander C. Ford. “Bi-directionality of Brain-Gut Interactions in Patients With Inflammatory Bowel Disease.” Gastroenterology 154, no. 6 (May 2018): 1635-1646.e3. https://doi.org/10.1053/j.gastro.2018.01.027.Full Text Link to Item
-
Gracie, David J., John P. Hamlin, and Alexander C. Ford. “Longitudinal impact of IBS-type symptoms on disease activity, healthcare utilization, psychological health, and quality of life in inflammatory bowel disease.” Am J Gastroenterol 113, no. 5 (May 2018): 702–12. https://doi.org/10.1038/s41395-018-0021-z.Full Text Link to Item
-
Gracie, David J., and Alexander C. Ford. “Defining the relationship between depression and disease activity in IBD using clinical disease activity indices: merit or misnomer?” Am J Gastroenterol 113, no. 5 (May 2018): 773–74. https://doi.org/10.1038/s41395-018-0014-y.Full Text Link to Item
-
Shearer, J., P. Paine, A. Agrawal, and A. C. Ford. “Efficacy of linaclotide in irritable bowel syndrome with constipation: Real-world data.” Neurogastroenterol Motil 30, no. 5 (May 2018): e13328. https://doi.org/10.1111/nmo.13328.Full Text Link to Item
-
Sood, Ruchit, and Alexander C. Ford. “Histologic Criteria to Define Irritable Bowel Syndrome: Within the Realms of Possibility?” Gastroenterology 154, no. 5 (April 2018): 1539–41. https://doi.org/10.1053/j.gastro.2018.03.009.Full Text Link to Item
-
Burr, Nicholas E., and Alexander C. Ford. “Possible Redundant Data in the Network Meta-analysis of Pharmacological Therapies for Opioid-Induced Constipation.” J Pain Symptom Manage 55, no. 3 (March 2018): e8–9. https://doi.org/10.1016/j.jpainsymman.2017.12.492.Full Text Link to Item
-
Driver, Robert J., Catherine Handforth, Ganesh Radhakrishna, Michael I. Bennett, Alexander C. Ford, and Simon M. Everett. “The Glasgow Prognostic Score at the Time of Palliative Esophageal Stent Insertion is a Predictive Factor of 30-Day Mortality and Overall Survival.” J Clin Gastroenterol 52, no. 3 (March 2018): 223–28. https://doi.org/10.1097/MCG.0000000000000773.Full Text Link to Item
-
Drossman, Douglas A., Jan Tack, Alexander C. Ford, Eva Szigethy, Hans Törnblom, and Lukas Van Oudenhove. “Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut-Brain Interaction): A Rome Foundation Working Team Report.” Gastroenterology 154, no. 4 (March 2018): 1140-1171.e1. https://doi.org/10.1053/j.gastro.2017.11.279.Full Text Link to Item
-
Eusebi, Leonardo H., Raguprakash Ratnakumaran, Yuhong Yuan, Masoud Solaymani-Dodaran, Franco Bazzoli, and Alexander C. Ford. “Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis.” Gut 67, no. 3 (March 2018): 430–40. https://doi.org/10.1136/gutjnl-2016-313589.Full Text Link to Item
-
Black, Christopher J., and Alexander C. Ford. “Defining the functional gastrointestinal disorders is challenging: are clinical symptoms alone sufficient?” Scand J Gastroenterol 53, no. 2 (February 2018): 140. https://doi.org/10.1080/00365521.2017.1420220.Full Text Link to Item
-
Lacy, Brian E., Alexander C. Ford, and Nicholas J. Talley. “Quality of Care and the Irritable Bowel Syndrome: Is Now the Time to Set Standards?” Am J Gastroenterol 113, no. 2 (February 2018): 167–69. https://doi.org/10.1038/ajg.2017.442.Full Text Link to Item
-
Bradley, Stephen, Sarah Alderson, Alexander C. Ford, and Robbie Foy. “General practitioners' perceptions of irritable bowel syndrome: a Q-methodological study.” Fam Pract 35, no. 1 (January 16, 2018): 74–79. https://doi.org/10.1093/fampra/cmx053.Full Text Link to Item
-
Black, Christopher J., Lesley A. Houghton, and Alexander C. Ford. “Insights into the evaluation and management of dyspepsia: recent developments and new guidelines.” Therap Adv Gastroenterol 11 (2018): 1756284818805597. https://doi.org/10.1177/1756284818805597.Full Text Link to Item
-
Derwa, Yannick, Christopher J. M. Williams, Ruchit Sood, Saqib Mumtaz, M Hassan Bholah, Christian P. Selinger, P John Hamlin, Alexander C. Ford, and David J. Gracie. “Factors affecting clinical decision-making in inflammatory bowel disease and the role of point-of-care calprotectin.” Therap Adv Gastroenterol 11 (2018): 1756283X17744739. https://doi.org/10.1177/1756283X17744739.Full Text Link to Item
-
Eusebi, Leonardo H., Raguprakash Ratnakumaran, Franco Bazzoli, and Alexander C. Ford. “Prevalence of Dyspepsia in Individuals With Gastroesophageal Reflux-Type Symptoms in the Community: A Systematic Review and Meta-analysis.” Clin Gastroenterol Hepatol 16, no. 1 (January 2018): 39-48.e1. https://doi.org/10.1016/j.cgh.2017.07.041.Full Text Link to Item
-
Ford, Alexander C. “Stool as a treatment for IBS: more questions than answers?” Lancet Gastroenterol Hepatol 3, no. 1 (January 2018): 2–3. https://doi.org/10.1016/S2468-1253(17)30337-0.Full Text Link to Item
-
Hall, Barry J., P John Hamlin, David J. Gracie, and Alexander C. Ford. “The Effect of Antidepressants on the Course of Inflammatory Bowel Disease.” Can J Gastroenterol Hepatol 2018 (2018): 2047242. https://doi.org/10.1155/2018/2047242.Full Text Link to Item
-
Kane, John S., Andrew J. Irvine, Yannick Derwa, Olorunda Rotimi, and Alexander C. Ford. “High prevalence of irritable bowel syndrome-type symptoms in microscopic colitis: implications for treatment.” Therap Adv Gastroenterol 11 (2018): 1756284818783600. https://doi.org/10.1177/1756284818783600.Full Text Link to Item
-
Kane, John S., Andrew J. Irvine, Yannick Derwa, and Alexander C. Ford. “Fatigue and its associated factors in microscopic colitis.” Therap Adv Gastroenterol 11 (2018): 1756284818799599. https://doi.org/10.1177/1756284818799599.Full Text Link to Item
-
Sagar, R. C., R. Sood, D. J. Gracie, M. J. Gold, N. To, G. R. Law, and A. C. Ford. “Cyclic vomiting syndrome is a prevalent and under-recognized condition in the gastroenterology outpatient clinic.” Neurogastroenterol Motil 30, no. 1 (January 2018). https://doi.org/10.1111/nmo.13174.Full Text Link to Item
-
Shearer, Jessica, Pavit Luthra, and Alexander C. Ford. “Cyclic vomiting syndrome: a case series and review of the literature.” Frontline Gastroenterol 9, no. 1 (January 2018): 2–9. https://doi.org/10.1136/flgastro-2016-100705.Full Text Link to Item
-
Camilleri, Michael, Alexander C. Ford, Gary M. Mawe, Phil G. Dinning, Satish S. Rao, William D. Chey, Magnus Simrén, Anthony Lembo, Tonia M. Young-Fadok, and Lin Chang. “Chronic constipation.” Nat Rev Dis Primers 3 (December 14, 2017): 17095. https://doi.org/10.1038/nrdp.2017.95.Full Text Link to Item
-
Selinger, Christian P., Marco V. Lenti, Tanya Clark, Helen Rafferty, David Gracie, Alexander C. Ford, Anthony OĘĽConnor, Tariq Ahmad, and P John Hamlin. “Infliximab Therapeutic Drug Monitoring Changes Clinical Decisions in a Virtual Biologics Clinic for Inflammatory Bowel Disease.” Inflamm Bowel Dis 23, no. 12 (December 2017): 2083–88. https://doi.org/10.1097/MIB.0000000000001258.Full Text Link to Item
-
Sood, Ruchit, Robbie Foy, and Alexander C. Ford. “Making a positive diagnosis of irritable bowel syndrome.” Br J Gen Pract 67, no. 665 (December 2017): 580–81. https://doi.org/10.3399/bjgp17X693857.Full Text Link to Item
-
Gracie, David J., and Alexander C. Ford. “A Bidirectional Relationship Between Symptom Reporting and Perceived Stress, But Not Disease Activity, in Inflammatory Bowel Disease: More Questions Than Answers?” Gastroenterology 153, no. 5 (November 2017): 1444–45. https://doi.org/10.1053/j.gastro.2017.09.035.Full Text Link to Item
-
Sagar, Rebecca C., and Alexander C. Ford. “Cyclic Vomiting Syndrome: Randomized Controlled Trials Are also Needed in Adults.” Am J Gastroenterol 112, no. 11 (November 2017): 1752–53. https://doi.org/10.1038/ajg.2017.293.Full Text Link to Item
-
Viggars, Andrew P., David J. Gracie, and Alexander C. Ford. “Use of Probiotics in Hospitalized Adults to Prevent Clostridium difficile Infection: DownGRADE the Quality of Evidence?” Gastroenterology 153, no. 5 (November 2017): 1451–52. https://doi.org/10.1053/j.gastro.2017.05.067.Full Text Link to Item
-
Camilleri, Michael, and Alexander C. Ford. “Pharmacotherapy for Irritable Bowel Syndrome.” J Clin Med 6, no. 11 (October 27, 2017). https://doi.org/10.3390/jcm6110101.Full Text Link to Item
-
Dang, Bobo, Haifan Wu, Vikram Khipple Mulligan, Marco Mravic, Yibing Wu, Thomas Lemmin, Alexander Ford, Daniel-Adriano Silva, David Baker, and William F. DeGrado. “De novo design of covalently constrained mesosize protein scaffolds with unique tertiary structures.” Proc Natl Acad Sci U S A 114, no. 41 (October 10, 2017): 10852–57. https://doi.org/10.1073/pnas.1710695114.Full Text Link to Item
-
Black, C. J., and A. C. Ford. “Editorial: subgroups in irritable bowel syndrome-more than just diarrhoea and constipation?” Aliment Pharmacol Ther 46, no. 7 (October 2017): 697. https://doi.org/10.1111/apt.14238.Full Text Link to Item
-
Headlam, John, Alexander C. Ford, and David J. Gracie. “Reactive Versus Proactive Therapeutic Drug Monitoring in Inflammatory Bowel Disease Patients Treated With Infliximab: A Self-Fulfilling Prophecy.” Clin Gastroenterol Hepatol 15, no. 10 (October 2017): 1638. https://doi.org/10.1016/j.cgh.2017.05.017.Full Text Link to Item
-
Appleton, Elizabeth S., Natasha A. Lee, and Alexander C. Ford. “Multiple myeloma presenting in association with gastric phytobezoar.” Clin Case Rep 5, no. 9 (September 2017): 1493–95. https://doi.org/10.1002/ccr3.1104.Full Text Link to Item
-
Gracie, D. J., Y. Derwa, P. J. Hamlin, and A. C. Ford. “Editorial: probiotics in inflammatory bowel disease-wrong organisms, wrong disease, or flawed concepts? Authors' reply.” Aliment Pharmacol Ther 46, no. 6 (September 2017): 633–34. https://doi.org/10.1111/apt.14237.Full Text Link to Item
-
Kane, John S., Olorunda Rotimi, and Alexander C. Ford. “Macroscopic findings, incidence and characteristics of microscopic colitis in a large cohort of patients from the United Kingdom.” Scand J Gastroenterol 52, no. 9 (September 2017): 988–94. https://doi.org/10.1080/00365521.2017.1334813.Full Text Link to Item
-
Moayyedi, Paul, Yuhong Yuan, Harith Baharith, and Alexander C. Ford. “Faecal microbiota transplantation for Clostridium difficile-associated diarrhoea: a systematic review of randomised controlled trials.” Med J Aust 207, no. 4 (August 21, 2017): 166–72. https://doi.org/10.5694/mja17.00295.Full Text Link to Item
-
Derwa, Y., D. J. Gracie, P. J. Hamlin, and A. C. Ford. “Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease.” Aliment Pharmacol Ther 46, no. 4 (August 2017): 389–400. https://doi.org/10.1111/apt.14203.Full Text Link to Item
-
Gracie, D. J., and A. C. Ford. “Editorial: mesalazine to prevent recurrent acute diverticulitis-the final nail in the coffin.” Aliment Pharmacol Ther 46, no. 4 (August 2017): 461–62. https://doi.org/10.1111/apt.14180.Full Text Link to Item
-
Gracie, David J., Christopher J. M. Williams, Ruchit Sood, Saqib Mumtaz, M Hassan Bholah, P John Hamlin, and Alexander C. Ford. “Reply.” Clin Gastroenterol Hepatol 15, no. 8 (August 2017): 1315–16. https://doi.org/10.1016/j.cgh.2017.04.035.Full Text Link to Item
-
Pinto-Sanchez, Maria Ines, Geoffrey B. Hall, Kathy Ghajar, Andrea Nardelli, Carolina Bolino, Jennifer T. Lau, Francois-Pierre Martin, et al. “Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome.” Gastroenterology 153, no. 2 (August 2017): 448-459.e8. https://doi.org/10.1053/j.gastro.2017.05.003.Full Text Link to Item
-
Pinto-Sánchez, María Inés, Natalia Causada-Calo, Premysl Bercik, Alexander C. Ford, Joseph A. Murray, David Armstrong, Carol Semrad, et al. “Safety of Adding Oats to a Gluten-Free Diet for Patients With Celiac Disease: Systematic Review and Meta-analysis of Clinical and Observational Studies.” Gastroenterology 153, no. 2 (August 2017): 395-409.e3. https://doi.org/10.1053/j.gastro.2017.04.009.Full Text Link to Item
-
Gracie, David J., and Alexander C. Ford. “Irritable Bowel Syndrome-Type Symptoms Are Associated With Psychological Comorbidity, Reduced Quality of Life, and Health Care Use in Patients With Inflammatory Bowel Disease.” Gastroenterology 153, no. 1 (July 2017): 324–25. https://doi.org/10.1053/j.gastro.2017.05.037.Full Text Link to Item
-
Hunt, Richard, David Armstrong, Peter Katelaris, Mary Afihene, Abate Bane, Shobna Bhatia, Min-Hu Chen, et al. “World Gastroenterology Organisation Global Guidelines: GERD Global Perspective on Gastroesophageal Reflux Disease.” J Clin Gastroenterol 51, no. 6 (July 2017): 467–78. https://doi.org/10.1097/MCG.0000000000000854.Full Text Link to Item
-
O’Connor, Anthony, Peter J. Hamlin, Jennifer Taylor, Christian Selinger, Nigel Scott, and Alexander C. Ford. “Postoperative prophylaxis in Crohn's disease after intestinal resection: a retrospective analysis.” Frontline Gastroenterol 8, no. 3 (July 2017): 203–9. https://doi.org/10.1136/flgastro-2016-100749.Full Text Link to Item
-
Ford, Alexander C., Brian E. Lacy, and Nicholas J. Talley. “Irritable Bowel Syndrome.” N Engl J Med 376, no. 26 (June 29, 2017): 2566–78. https://doi.org/10.1056/NEJMra1607547.Full Text Link to Item
-
Sood, R., D. J. Gracie, M. J. Gold, N. To, M. I. Pinto-Sanchez, P. Bercik, P. Moayyedi, A. C. Ford, and G. R. Law. “Editorial: latent class analysis to improve confidence in the diagnosis of IBS - authors' reply.” Aliment Pharmacol Ther 45, no. 9 (May 2017): 1268–69. https://doi.org/10.1111/apt.14012.Full Text Link to Item
-
Irvine, Andrew J., Maria Ines Pinto-Sanchez, Premysl Bercik, Paul Moayyedi, and Alexander C. Ford. “Minimal differences in prevalence and spectrum of organic disease at upper gastrointestinal endoscopy between selected secondary care patients with symptoms of gastro-oesophageal reflux or dyspepsia.” Scand J Gastroenterol 52, no. 4 (April 2017): 396–402. https://doi.org/10.1080/00365521.2016.1267792.Full Text Link to Item
-
O’Connor, Anthony, Colm A. O’Morain, and Alexander C. Ford. “Population screening and treatment of Helicobacter pylori infection.” Nat Rev Gastroenterol Hepatol 14, no. 4 (April 2017): 230–40. https://doi.org/10.1038/nrgastro.2016.195.Full Text Link to Item
-
Simpkins, S. J., M. I. Pintos-Sanchez, P. Moayyedi, P. Bercik, D. G. Morgan, C. Bolino, and A. C. Ford. “Letter: NICE referral criteria for lower gastrointestinal alarm features - not ideal but not poor either. Authors' reply.” Aliment Pharmacol Ther 45, no. 8 (April 2017): 1176. https://doi.org/10.1111/apt.13996.Full Text Link to Item
-
Ford, Alexander C., Pavit Luthra, Jan Tack, Guy E. Boeckxstaens, Paul Moayyedi, and Nicholas J. Talley. “Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta-analysis.” Gut 66, no. 3 (March 2017): 411–20. https://doi.org/10.1136/gutjnl-2015-310721.Full Text Link to Item
-
Gracie, D. J., and A. C. Ford. “Letter: causes of fatigue in inflammatory bowel disease remain uncertain.” Aliment Pharmacol Ther 45, no. 5 (March 2017): 762–63. https://doi.org/10.1111/apt.13922.Full Text Link to Item
-
Gracie, David J., Andrew J. Irvine, Ruchit Sood, Antonina Mikocka-Walus, P John Hamlin, and Alexander C. Ford. “Effect of psychological therapy on disease activity, psychological comorbidity, and quality of life in inflammatory bowel disease: a systematic review and meta-analysis.” Lancet Gastroenterol Hepatol 2, no. 3 (March 2017): 189–99. https://doi.org/10.1016/S2468-1253(16)30206-0.Full Text Link to Item
-
Gracie, David J., Christopher J. M. Williams, Ruchit Sood, Saqib Mumtaz, M Hassan Bholah, P John Hamlin, and Alexander C. Ford. “Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome-type Symptoms in Patients With Inflammatory Bowel Disease.” Clin Gastroenterol Hepatol 15, no. 3 (March 2017): 376-384.e5. https://doi.org/10.1016/j.cgh.2016.05.012.Full Text Link to Item
-
Sood, R., D. J. Gracie, M. J. Gold, N. To, M. I. Pinto-Sanchez, P. Bercik, P. Moayyedi, A. C. Ford, and G. R. Law. “Derivation and validation of a diagnostic test for irritable bowel syndrome using latent class analysis.” Aliment Pharmacol Ther 45, no. 6 (March 2017): 824–32. https://doi.org/10.1111/apt.13949.Full Text Link to Item
-
Sood, R., and A. C. Ford. “Editorial: volatile organic compounds in irritable bowel syndrome - technology for an accurate and reliable point-of-care test?” Aliment Pharmacol Ther 45, no. 4 (February 2017): 563–64. https://doi.org/10.1111/apt.13896.Full Text Link to Item
-
Camilleri, Michael, and Alexander C. Ford. “Irritable Bowel Syndrome: Pathophysiology and Current Therapeutic Approaches.” Handb Exp Pharmacol 239 (2017): 75–113. https://doi.org/10.1007/164_2016_102.Full Text Link to Item
-
Gracie, David J., and Alexander C. Ford. “Ongoing Symptoms in Ulcerative Colitis Patients in Remission: Irritable Bowel Syndrome or Gastrointestinal Symptoms in the Absence of Inflammation?” Inflamm Bowel Dis 23, no. 1 (January 2017): E4–5. https://doi.org/10.1097/MIB.0000000000000984.Full Text Link to Item
-
Irvine, Andrew J., William D. Chey, and Alexander C. Ford. “Screening for Celiac Disease in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis.” Am J Gastroenterol 112, no. 1 (January 2017): 65–76. https://doi.org/10.1038/ajg.2016.466.Full Text Link to Item
-
Selinger, C. P., I. Carbery, V. Warren, A. F. Rehman, C. J. Williams, S. Mumtaz, H. Bholah, et al. “The relationship between different information sources and disease-related patient knowledge and anxiety in patients with inflammatory bowel disease.” Aliment Pharmacol Ther 45, no. 1 (January 2017): 63–74. https://doi.org/10.1111/apt.13831.Full Text Link to Item
-
Simpkins, S. J., M. I. Pinto-Sanchez, P. Moayyedi, P. Bercik, D. G. Morgan, C. Bolino, and A. C. Ford. “Poor predictive value of lower gastrointestinal alarm features in the diagnosis of colorectal cancer in 1981 patients in secondary care.” Aliment Pharmacol Ther 45, no. 1 (January 2017): 91–99. https://doi.org/10.1111/apt.13846.Full Text Link to Item
-
Sood, Ruchit, and Alexander C. Ford. “Derivation and Validation of a Panel of Exhaled Volatile Organic Compounds in Differentiating Irritable Bowel Syndrome From Health.” Gastroenterology 151, no. 6 (December 2016): 1245–46. https://doi.org/10.1053/j.gastro.2016.10.028.Full Text Link to Item
-
Gracie, David J., and Alexander C. Ford. “Editorial: Using Patient-Reported Outcome Measures in Gastroenterology: PROMISed Land or Road to Nowhere?” Am J Gastroenterol 111, no. 11 (November 2016): 1557–58. https://doi.org/10.1038/ajg.2016.415.Full Text Link to Item
-
Gracie, David J., and Alexander C. Ford. “The possible risks of proton pump inhibitors.” Med J Aust 205, no. 7 (October 3, 2016): 292–93. https://doi.org/10.5694/mja16.00750.Full Text Link to Item
-
Gracie, D. J., and A. C. Ford. “Editorial: challenging established perceptions of brain-gut interactions in functional gastrointestinal disorders - brain-gut, gut-brain, or both?” Aliment Pharmacol Ther 44, no. 8 (October 2016): 899–900. https://doi.org/10.1111/apt.13762.Full Text Link to Item
-
Gracie, David J., Christopher J. M. Williams, Ruchit Sood, Saqib Mumtaz, M Hassan Bholah, P John Hamlin, and Alexander C. Ford. “Response to Levenstein and Prantera.” Am J Gastroenterol 111, no. 10 (October 2016): 1499. https://doi.org/10.1038/ajg.2016.322.Full Text Link to Item
-
Gracie, David J., and Alexander C. Ford. “Depression Is Associated With Subjective Measures of Crohn's Disease Activity During Longitudinal Follow-up.” Gastroenterology 151, no. 4 (October 2016): 762–63. https://doi.org/10.1053/j.gastro.2016.08.037.Full Text Link to Item
-
Holtmann, Gerald J., Alexander C. Ford, and Nicholas J. Talley. “Pathophysiology of irritable bowel syndrome.” Lancet Gastroenterol Hepatol 1, no. 2 (October 2016): 133–46. https://doi.org/10.1016/S2468-1253(16)30023-1.Full Text Link to Item
-
Kane, John S., Ruchit Sood, Graham R. Law, David J. Gracie, Natalie To, Matthew J. Gold, and Alexander C. Ford. “Validation and modification of a diagnostic scoring system to predict microscopic colitis.” Scand J Gastroenterol 51, no. 10 (October 2016): 1206–12. https://doi.org/10.1080/00365521.2016.1186221.Full Text Link to Item
-
Sood, Ruchit, Michael Camilleri, David J. Gracie, Matthew J. Gold, Natalie To, Graham R. Law, and Alexander C. Ford. “Enhancing Diagnostic Performance of Symptom-Based Criteria for Irritable Bowel Syndrome by Additional History and Limited Diagnostic Evaluation.” Am J Gastroenterol 111, no. 10 (October 2016): 1446–54. https://doi.org/10.1038/ajg.2016.308.Full Text Link to Item
-
Marsden, Sarah L., and Alexander C. Ford. “Imipramine for Treatment of Esophageal Hypersensitivity and Functional Heartburn.” Am J Gastroenterol 111, no. 9 (September 2016): 1358. https://doi.org/10.1038/ajg.2016.160.Full Text Link to Item
-
Sood, Ruchit, and Alexander C. Ford. “Diagnosis: Rome IV criteria for FGIDs - an improvement or more of the same?” Nat Rev Gastroenterol Hepatol 13, no. 9 (September 2016): 501–2. https://doi.org/10.1038/nrgastro.2016.110.Full Text Link to Item
-
Turvill, James, Shaun O’Connell, Abigail Brooks, Karen Bradley-Wood, James Laing, Swaminathan Thiagarajan, David Hammond, et al. “Evaluation of a faecal calprotectin care pathway for use in primary care.” Prim Health Care Res Dev 17, no. 5 (September 2016): 428–36. https://doi.org/10.1017/S1463423616000049.Full Text Link to Item
-
Luthra, Pavit, and Alexander C. Ford. “Screening for Celiac Disease in Individuals With Symptoms Suggestive of Irritable Bowel Syndrome: Still a Worthwhile Exercise.” Gastroenterology 151, no. 2 (August 2016): 368–70. https://doi.org/10.1053/j.gastro.2016.06.029.Full Text Link to Item
-
To, Natalie, David J. Gracie, and Alexander C. Ford. “The Importance of Smoking Cessation in Improving Disease Course in Crohn's Disease.” Am J Gastroenterol 111, no. 8 (August 2016): 1198. https://doi.org/10.1038/ajg.2016.165.Full Text Link to Item
-
Gracie, David J., and Alexander C. Ford. “Psychological Comorbidity and Inflammatory Bowel Disease Activity: Cause or Effect?” Clin Gastroenterol Hepatol 14, no. 7 (July 2016): 1061–62. https://doi.org/10.1016/j.cgh.2016.02.007.Full Text Link to Item
-
O’Connor, Anthony, Maria Marples, Clive Mulatero, John Hamlin, and Alexander C. Ford. “Ipilimumab-induced colitis: experience from a tertiary referral center.” Therap Adv Gastroenterol 9, no. 4 (July 2016): 457–62. https://doi.org/10.1177/1756283X16646709.Full Text Link to Item
-
To, N., A. C. Ford, and D. J. Gracie. “Systematic review with meta-analysis: the effect of tobacco smoking on the natural history of ulcerative colitis.” Aliment Pharmacol Ther 44, no. 2 (July 2016): 117–26. https://doi.org/10.1111/apt.13663.Full Text Link to Item
-
Gracie, David J., and Alexander C. Ford. “Simple Clinical Colitis Activity Index: Accurate Assessment of Inflammatory Burden or Reflection of Low Mood and Somatoform Behavior?” Am J Gastroenterol 111, no. 6 (June 2016): 900–901. https://doi.org/10.1038/ajg.2016.93.Full Text Link to Item
-
To, N., D. J. Gracie, and A. C. Ford. “Letter: biologics are effective in neutralising the detrimental effect of smoking on the natural course of Crohn's disease - authors' reply.” Aliment Pharmacol Ther 43, no. 11 (June 2016): 1246. https://doi.org/10.1111/apt.13606.Full Text Link to Item
-
To, N., D. J. Gracie, and A. C. Ford. “Letter: deleterious effects of smoking on post-operative Crohn's disease - authors' reply.” Aliment Pharmacol Ther 43, no. 11 (June 2016): 1248. https://doi.org/10.1111/apt.13613.Full Text Link to Item
-
Kamp, Eline J. C. A., John S. Kane, and Alexander C. Ford. “Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta-analysis.” Clin Gastroenterol Hepatol 14, no. 5 (May 2016): 659-68.e1. https://doi.org/10.1016/j.cgh.2015.09.031.Full Text Link to Item
-
Kane, John S., Olorunda Rotimi, Simon M. Everett, and Alexander C. Ford. “Reply.” Clin Gastroenterol Hepatol 14, no. 5 (May 2016): 779. https://doi.org/10.1016/j.cgh.2016.02.001.Full Text Link to Item
-
Ford, Alexander C., Kurinchi Selvan Gurusamy, Brendan Delaney, David Forman, and Paul Moayyedi. “Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people.” Cochrane Database Syst Rev 4, no. 4 (April 19, 2016): CD003840. https://doi.org/10.1002/14651858.CD003840.pub5.Full Text Link to Item
-
Gracie, David J., Christopher J. M. Williams, Ruchit Sood, Saqib Mumtaz, M Hassan Bholah, P John Hamlin, and Alexander C. Ford. “Poor Correlation Between Clinical Disease Activity and Mucosal Inflammation, and the Role of Psychological Comorbidity, in Inflammatory Bowel Disease.” Am J Gastroenterol 111, no. 4 (April 2016): 541–51. https://doi.org/10.1038/ajg.2016.59.Full Text Link to Item
-
O’Connor, Anthony, and Alexander C. Ford. “Poor Correlation Between Patient-reported and Endoscopic Components of the Mayo Score in Ulcerative Colitis.” Gastroenterology 150, no. 4 (April 2016): 1037–39. https://doi.org/10.1053/j.gastro.2016.02.054.Full Text Link to Item
-
Talley, Nicholas J., and Alexander C. Ford. “Functional Dyspepsia.” N Engl J Med 374, no. 9 (March 3, 2016): 896. https://doi.org/10.1056/NEJMc1515497.Full Text Link to Item
-
Bidmead, T. P., and A. C. Ford. “Antibiotic use and subsequent development of functional gastrointestinal disorders: effect of symptom-reporting and consultation behavior.” Neurogastroenterol Motil 28, no. 3 (March 2016): 449–50. https://doi.org/10.1111/nmo.12746.Full Text Link to Item
-
To, N., D. J. Gracie, and A. C. Ford. “Systematic review with meta-analysis: the adverse effects of tobacco smoking on the natural history of Crohn's disease.” Aliment Pharmacol Ther 43, no. 5 (March 2016): 549–61. https://doi.org/10.1111/apt.13511.Full Text Link to Item
-
Mahadeva, S., and A. C. Ford. “Clinical and epidemiological differences in functional dyspepsia between the East and the West.” Neurogastroenterol Motil 28, no. 2 (February 2016): 167–74. https://doi.org/10.1111/nmo.12657.Full Text Link to Item
-
To, N., D. J. Gracie, and A. C. Ford. “Letter: smoking as a modifiable risk factor for a complicated course in Crohn's disease.” Aliment Pharmacol Ther 43, no. 3 (February 2016): 440. https://doi.org/10.1111/apt.13476.Full Text Link to Item
-
Kane, John S., and Alexander C. Ford. “Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome.” Expert Rev Gastroenterol Hepatol 10, no. 4 (2016): 431–42. https://doi.org/10.1586/17474124.2016.1140571.Full Text Link to Item
-
Min, Thazin, and Alexander C. Ford. “Efficacy of mesalazine in IBS.” Gut 65, no. 1 (January 2016): 187–88. https://doi.org/10.1136/gutjnl-2015-309593.Full Text Link to Item
-
Sood, Ruchit, and Alexander C. Ford. “Validation of a Serum Biomarker for Irritable Bowel Syndrome: Is an Accurate, Single Biomarker Test Possible?” Gastroenterology 150, no. 1 (January 2016): 277–78. https://doi.org/10.1053/j.gastro.2015.10.010.Full Text Link to Item
-
Talley, Nicholas J., and Alexander C. Ford. “Functional Dyspepsia.” N Engl J Med 373, no. 19 (November 5, 2015): 1853–63. https://doi.org/10.1056/NEJMra1501505.Full Text Link to Item
-
Ford, Alexander C. “Is it Time to Rethink Screening of Individuals With Symptoms of Irritable Bowel Syndrome for Celiac Disease?” Clin Gastroenterol Hepatol 13, no. 11 (November 2015): 1944–45. https://doi.org/10.1016/j.cgh.2015.07.039.Full Text Link to Item
-
Gracie, David J., and Alexander C. Ford. “Defining the relationship between clinical and biochemical disease activity indices and perceived stress in inflammatory bowel disease.” Gastroenterology 149, no. 6 (November 2015): 1632–34. https://doi.org/10.1053/j.gastro.2015.09.024.Full Text Link to Item
-
Sood, Ruchit, and Alexander C. Ford. “Use of Biomarkers in Irritable Bowel Syndrome: To Predict the Future, Look at the Past.” Clin Transl Gastroenterol 6, no. 10 (October 8, 2015): e116. https://doi.org/10.1038/ctg.2015.41.Full Text Link to Item
-
Manship, Thomas A., and Alexander C. Ford. “VSL#3 in Postoperative Crohn's Disease.” Clin Gastroenterol Hepatol 13, no. 10 (October 2015): 1855. https://doi.org/10.1016/j.cgh.2015.01.024.Full Text Link to Item
-
Aziz, Imran, Saqib Mumtaz, Hassan Bholah, Fahmid U. Chowdhury, David S. Sanders, and Alexander C. Ford. “High Prevalence of Idiopathic Bile Acid Diarrhea Among Patients With Diarrhea-Predominant Irritable Bowel Syndrome Based on Rome III Criteria.” Clin Gastroenterol Hepatol 13, no. 9 (September 2015): 1650-5.e2. https://doi.org/10.1016/j.cgh.2015.03.002.Full Text Link to Item
-
Gracie, David J., and Alexander C. Ford. “Symbiotics in irritable bowel syndrome--better than probiotics alone?” Curr Opin Clin Nutr Metab Care 18, no. 5 (September 2015): 485–89. https://doi.org/10.1097/MCO.0000000000000199.Full Text Link to Item
-
Slattery, S. A., O. Niaz, Q. Aziz, A. C. Ford, and A. D. Farmer. “Letter: therapeutic trial is more informative than SeHCAT to diagnose bile acid malabsorption--authors' reply.” Aliment Pharmacol Ther 42, no. 6 (September 2015): 781. https://doi.org/10.1111/apt.13337.Full Text Link to Item
-
Sood, R., D. J. Gracie, G. R. Law, and A. C. Ford. “Systematic review with meta-analysis: the accuracy of diagnosing irritable bowel syndrome with symptoms, biomarkers and/or psychological markers.” Aliment Pharmacol Ther 42, no. 5 (September 2015): 491–503. https://doi.org/10.1111/apt.13283.Full Text Link to Item
-
Moayyedi, Paul, Eamonn M. M. Quigley, Brian E. Lacy, Anthony J. Lembo, Yuri A. Saito, Lawrence R. Schiller, Edy E. Soffer, Brennan M. R. Spiegel, and Alexander C. Ford. “The Effect of Dietary Intervention on Irritable Bowel Syndrome: A Systematic Review.” Clin Transl Gastroenterol 6, no. 8 (August 20, 2015): e107. https://doi.org/10.1038/ctg.2015.21.Full Text Link to Item
-
Davies, Catherine L., and Alexander C. Ford. “Pinaverium in Irritable Bowel Syndrome: Old Drug, New Tricks?” Clin Gastroenterol Hepatol 13, no. 8 (August 2015): 1548–49. https://doi.org/10.1016/j.cgh.2015.03.007.Full Text Link to Item
-
Luthra, Pavit, and Alexander C. Ford. “Irritable Bowel Syndrome and Colorectal Neoplasia: "Cause and Effect" or Chance Association?” Gastroenterology 149, no. 2 (August 2015): 502–3. https://doi.org/10.1053/j.gastro.2015.06.033.Full Text Link to Item
-
Ford, Alexander C., David Forman, Richard Hunt, Yuhong Yuan, and Paul Moayyedi. “Helicobacter pylori eradication for the prevention of gastric neoplasia.” Cochrane Database Syst Rev 2015, no. 7 (July 22, 2015): CD005583. https://doi.org/10.1002/14651858.CD005583.pub2.Full Text Link to Item
-
Ford, Alexander C. “Aetiopathogenesis of functional dyspepsia.” Gut 64, no. 7 (July 2015): 1182–83. https://doi.org/10.1136/gutjnl-2014-308959.Full Text Link to Item
-
Ford, Alexander C., Avantika Marwaha, Ruchit Sood, and Paul Moayyedi. “Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis.” Gut 64, no. 7 (July 2015): 1049–57. https://doi.org/10.1136/gutjnl-2014-307843.Full Text Link to Item
-
Gracie, D. J., P. Bercik, D. G. Morgan, C. Bolino, M. I. Pintos-Sanchez, P. Moayyedi, and A. C. Ford. “No increase in prevalence of somatization in functional vs organic dyspepsia: a cross-sectional survey.” Neurogastroenterol Motil 27, no. 7 (July 2015): 1024–31. https://doi.org/10.1111/nmo.12578.Full Text Link to Item
-
Lau, Michelle S. Y., and Alexander C. Ford. “Do Lay People Accept a Positive Diagnosis of Irritable Bowel Syndrome?” Gastroenterology 149, no. 1 (July 2015): 252–53. https://doi.org/10.1053/j.gastro.2015.05.019.Full Text Link to Item
-
Littlehales, Emma G., and Alexander C. Ford. “Lubiprostone Is Effective in Treating Functional Bowel Disease With Constipation.” Clin Gastroenterol Hepatol 13, no. 7 (July 2015): 1378–79. https://doi.org/10.1016/j.cgh.2014.09.048.Full Text Link to Item
-
Luthra, Pavit, and Alexander C. Ford. “Ondansetron and irritable bowel syndrome.” Gut 64, no. 7 (July 2015): 1181. https://doi.org/10.1136/gutjnl-2014-307551.Full Text Link to Item
-
Patel, Purav, Premysl Bercik, David G. Morgan, Carolina Bolino, Maria Ines Pintos-Sanchez, Paul Moayyedi, and Alexander C. Ford. “Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: cross-sectional survey.” Scand J Gastroenterol 50, no. 7 (July 2015): 816–23. https://doi.org/10.3109/00365521.2015.1007079.Full Text Link to Item
-
Pinto-Sanchez, Maria Ines, Alexander C. Ford, Christian A. Avila, Elena F. Verdu, Stephen M. Collins, David Morgan, Paul Moayyedi, and Premysl Bercik. “Anxiety and Depression Increase in a Stepwise Manner in Parallel With Multiple FGIDs and Symptom Severity and Frequency.” Am J Gastroenterol 110, no. 7 (July 2015): 1038–48. https://doi.org/10.1038/ajg.2015.128.Full Text Link to Item
-
Slattery, S. A., O. Niaz, Q. Aziz, A. C. Ford, and A. D. Farmer. “Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea.” Aliment Pharmacol Ther 42, no. 1 (July 2015): 3–11. https://doi.org/10.1111/apt.13227.Full Text Link to Item
-
Dube, S., and A. C. Ford. “Efficacy of hypnotherapy in one thousand patients with irritable bowel syndrome.” Aliment Pharmacol Ther 41, no. 11 (June 2015): 1222–23. https://doi.org/10.1111/apt.13184.Full Text Link to Item
-
Kane, John S., Olorunda Rotimi, Simon M. Everett, Shairoz Samji, Flurina Michelotti, and Alexander C. Ford. “Development and validation of a scoring system to identify patients with microscopic colitis.” Clin Gastroenterol Hepatol 13, no. 6 (June 2015): 1125–31. https://doi.org/10.1016/j.cgh.2014.12.035.Full Text Link to Item
-
Luthra, P., L. Peyrin-Biroulet, and A. C. Ford. “Systematic review and meta-analysis: opportunistic infections and malignancies during treatment with anti-integrin antibodies in inflammatory bowel disease.” Aliment Pharmacol Ther 41, no. 12 (June 2015): 1227–36. https://doi.org/10.1111/apt.13215.Full Text Link to Item
-
Sood, Ruchit, and Alexander C. Ford. “Combining biomarkers in irritable bowel syndrome: a forward step toward making a positive diagnosis and directing therapy?” Gastroenterology 148, no. 7 (June 2015): 1471–73. https://doi.org/10.1053/j.gastro.2015.04.032.Full Text Link to Item
-
Aziz, Imran, Matthew Kurien, David S. Sanders, and Alexander C. Ford. “Screening for bile acid diarrhoea in suspected irritable bowel syndrome.” Gut 64, no. 5 (May 2015): 851. https://doi.org/10.1136/gutjnl-2014-307579.Full Text Link to Item
-
Ford, Alexander C., Paul Moayyedi, Premysl Bercik, David G. Morgan, Carolina Bolino, Maria I. Pintos-Sanchez, and Walter Reinisch. “Lack of utility of symptoms and signs at first presentation as predictors of inflammatory bowel disease in secondary care.” Am J Gastroenterol 110, no. 5 (May 2015): 716–24. https://doi.org/10.1038/ajg.2015.117.Full Text Link to Item
-
Lopez, Anthony, Alexander C. Ford, Jean-Frédéric Colombel, Walter Reinisch, William J. Sandborn, and Laurent Peyrin-Biroulet. “Efficacy of tumour necrosis factor antagonists on remission, colectomy and hospitalisations in ulcerative colitis: Meta-analysis of placebo-controlled trials.” Dig Liver Dis 47, no. 5 (May 2015): 356–64. https://doi.org/10.1016/j.dld.2015.01.148.Full Text Link to Item
-
Patel, P., and A. C. Ford. “Irritable bowel syndrome and somatization.” Neurogastroenterol Motil 27, no. 5 (May 2015): 740. https://doi.org/10.1111/nmo.12528.Full Text Link to Item
-
Quinn, James A., and Alexander C. Ford. “Comment on "A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome" by Guillaume Pineton de Chambrun et al. [Digestive and Liver Disease 2015;47:119-24].” Dig Liver Dis 47, no. 5 (May 2015): 437. https://doi.org/10.1016/j.dld.2015.01.002.Full Text Link to Item
-
Shivaji, Uday N., and Alexander C. Ford. “Beliefs about management of irritable bowel syndrome in primary care: cross-sectional survey in one locality.” Prim Health Care Res Dev 16, no. 3 (May 2015): 263–69. https://doi.org/10.1017/S1463423614000383.Full Text Link to Item
-
Patel, P., and A. C. Ford. “Letter: irritable bowel syndrome is significantly associated with somatisation - authors' reply.” Aliment Pharmacol Ther 41, no. 8 (April 2015): 791–92. https://doi.org/10.1111/apt.13116.Full Text Link to Item
-
Patel, P., P. Bercik, D. G. Morgan, C. Bolino, M. I. Pintos-Sanchez, P. Moayyedi, and A. C. Ford. “Irritable bowel syndrome is significantly associated with somatisation in 840 patients, which may drive bloating.” Aliment Pharmacol Ther 41, no. 5 (March 2015): 449–58. https://doi.org/10.1111/apt.13074.Full Text Link to Item
-
Kane, John S., Hannah Bryan, and Alexander C. Ford. “Reducing the need for random colonic biopsies in patients with diarrhea.” Am J Gastroenterol 110, no. 2 (February 2015): 351–52. https://doi.org/10.1038/ajg.2014.401.Full Text Link to Item
-
Sood, Ruchit, Saqib Ansari, Tanya Clark, P John Hamlin, and Alexander C. Ford. “Long-term efficacy and safety of azathioprine in ulcerative colitis.” J Crohns Colitis 9, no. 2 (February 2015): 191–97. https://doi.org/10.1093/ecco-jcc/jju010.Full Text Link to Item
-
Gracie, David J., and Alexander C. Ford. “IBS-like symptoms in patients with ulcerative colitis.” Clin Exp Gastroenterol 8 (2015): 101–9. https://doi.org/10.2147/CEG.S58153.Full Text Link to Item
-
Sood, Ruchit, and Alexander C. Ford. “Central pain processing in irritable bowel syndrome is modulated by mood: a mechanism for the beneficial effects of antidepressants?” Gastroenterology 148, no. 1 (January 2015): 247–48. https://doi.org/10.1053/j.gastro.2014.11.017.Full Text Link to Item
-
Ford, Alexander C., Pavit Luthra, Stephen B. Hanauer, Simon P. Travis, M Scott Harris, and Walter Reinisch. “Placebo response rate in clinical trials of fistulizing Crohn's disease: systematic review and meta-analysis.” Clin Gastroenterol Hepatol 12, no. 12 (December 2014): 1981–90. https://doi.org/10.1016/j.cgh.2014.08.038.Full Text Link to Item
-
Gracie, David J., and Alexander C. Ford. “Functional bowel symptoms in quiescent inflammatory bowel disease: more than just irritable bowel syndrome?” Gastroenterology 147, no. 5 (November 2014): 1176–77. https://doi.org/10.1053/j.gastro.2014.09.008.Full Text Link to Item
-
Jones, M. P., M. M. Walker, A. C. Ford, and N. J. Talley. “Editorial: the overlap of atopy and functional gastrointestinal disorders in primary care--authors' reply.” Aliment Pharmacol Ther 40, no. 10 (November 2014): 1244–45. https://doi.org/10.1111/apt.12961.Full Text Link to Item
-
Sood, Ruchit, Graham R. Law, and Alexander C. Ford. “Diagnosis of IBS: symptoms, symptom-based criteria, biomarkers or 'psychomarkers'?” Nat Rev Gastroenterol Hepatol 11, no. 11 (November 2014): 683–91. https://doi.org/10.1038/nrgastro.2014.127.Full Text Link to Item
-
Ford, A. C., N. J. Talley, M. M. Walker, and M. P. Jones. “Increased prevalence of autoimmune diseases in functional gastrointestinal disorders: case-control study of 23471 primary care patients.” Aliment Pharmacol Ther 40, no. 7 (October 2014): 827–34. https://doi.org/10.1111/apt.12903.Full Text Link to Item
-
Ford, Alexander C., Eamonn M. M. Quigley, Brian E. Lacy, Anthony J. Lembo, Yuri A. Saito, Lawrence R. Schiller, Edy E. Soffer, Brennan M. R. Spiegel, and Paul Moayyedi. “Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis.” Am J Gastroenterol 109, no. 10 (October 2014): 1547–61. https://doi.org/10.1038/ajg.2014.202.Full Text Link to Item
-
Shivaji, Uday N., and Alexander C. Ford. “Prevalence of functional gastrointestinal disorders among consecutive new patient referrals to a gastroenterology clinic.” Frontline Gastroenterol 5, no. 4 (October 2014): 266–71. https://doi.org/10.1136/flgastro-2013-100426.Full Text Link to Item
-
Ford, Alexander C., Eamonn M. M. Quigley, Brian E. Lacy, Anthony J. Lembo, Yuri A. Saito, Lawrence R. Schiller, Edy E. Soffer, Brennan M. R. Spiegel, and Paul Moayyedi. “Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis.” Am J Gastroenterol 109, no. 9 (September 2014): 1350–65. https://doi.org/10.1038/ajg.2014.148.Full Text Link to Item
-
Moayyedi, Paul, Eamonn M. M. Quigley, Brian E. Lacy, Anthony J. Lembo, Yuri A. Saito, Lawrence R. Schiller, Edy E. Soffer, Brennan M. R. Spiegel, and Alexander C. Ford. “The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis.” Am J Gastroenterol 109, no. 9 (September 2014): 1367–74. https://doi.org/10.1038/ajg.2014.195.Full Text Link to Item
-
Ford, Alexander C., Paul Moayyedi, Brian E. Lacy, Anthony J. Lembo, Yuri A. Saito, Lawrence R. Schiller, Edy E. Soffer, Brennan M. R. Spiegel, Eamonn M. M. Quigley, and Eamonn M. M. Task Force on the Management of Functional Bowel Disorders. “American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation.” Am J Gastroenterol 109 Suppl 1 (August 2014): S2-26. https://doi.org/10.1038/ajg.2014.187.Full Text Link to Item
-
Jones, M. P., M. M. Walker, A. C. Ford, and N. J. Talley. “The overlap of atopy and functional gastrointestinal disorders among 23,471 patients in primary care.” Aliment Pharmacol Ther 40, no. 4 (August 2014): 382–91. https://doi.org/10.1111/apt.12846.Full Text Link to Item
-
Luthra, Pavit, and Alexander C. Ford. “The fall and rise of 5-hydroxytryptamine receptor antagonists in irritable bowel syndrome with diarrhea.” Gastroenterology 147, no. 2 (August 2014): 527–28. https://doi.org/10.1053/j.gastro.2014.06.017.Full Text Link to Item
-
Vidal, Adriana C., Jennifer S. Smith, Fidel Valea, Rex Bentley, Maggie Gradison, Kimberly S. H. Yarnall, Anne Ford, et al. “HPV genotypes and cervical intraepithelial neoplasia in a multiethnic cohort in the southeastern USA.” Cancer Causes Control 25, no. 8 (August 2014): 1055–62. https://doi.org/10.1007/s10552-014-0406-2.Full Text Link to Item
-
Gizard, E., A. C. Ford, J. -. P. Bronowicki, and L. Peyrin-Biroulet. “Systematic review: The epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease.” Aliment Pharmacol Ther 40, no. 1 (July 2014): 3–15. https://doi.org/10.1111/apt.12794.Full Text Link to Item
-
Gracie, D. J., and A. C. Ford. “Letter: is there a bi-directional relationship between depression and IBD?” Aliment Pharmacol Ther 40, no. 2 (July 2014): 213. https://doi.org/10.1111/apt.12802.Full Text Link to Item
-
Shivaji, U. N., F. U. Chowdhury, and A. C. Ford. “Letter: bile acid diarrhoea is not a rare cause of diarrhoea in secondary care.” Aliment Pharmacol Ther 40, no. 2 (July 2014): 216. https://doi.org/10.1111/apt.12821.Full Text Link to Item
-
Ford, Alexander C., David Forman, Richard H. Hunt, Yuhong Yuan, and Paul Moayyedi. “Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials.” Bmj 348 (May 20, 2014): g3174. https://doi.org/10.1136/bmj.g3174.Full Text Link to Item
-
Ford, Alexander C., and Paul Moayyedi. “Whom should we "test and treat" for Helicobacter pylori?” Bmj 348 (May 20, 2014): g3320. https://doi.org/10.1136/bmj.g3320.Full Text Link to Item
-
Choi, Grace K. H., Stephanie D. E. Collins, Daniel P. Greer, Lisa Warren, Grace Dowson, Tanya Clark, P John Hamlin, and Alexander C. Ford. “Costs of adalimumab versus infliximab as first-line biological therapy for luminal Crohn's disease.” J Crohns Colitis 8, no. 5 (May 2014): 375–83. https://doi.org/10.1016/j.crohns.2013.09.017.Full Text Link to Item
-
Sood, Ruchit, and Alexander C. Ford. “Diagnosing irritable bowel syndrome with a combination of biomarkers and "psychomarkers".” Gastroenterology 146, no. 5 (May 2014): 1418–20. https://doi.org/10.1053/j.gastro.2014.03.028.Full Text Link to Item
-
Cottom, Hannah, Alexander C. Ford, and Olorunda Rotimi. “Masquerading gastrointestinal polyps: air on the side of caution? Cystic pneumatosis.” Gastroenterology 146, no. 4 (April 2014): e9-10. https://doi.org/10.1053/j.gastro.2013.11.043.Full Text Link to Item
-
Ford, Alexander C., Laura F. Glenn, and Paul Moayyedi. “Rates of upper gastrointestinal endoscopy and gastro-oesophageal malignancy outcomes.” Gut 63, no. 4 (April 2014): 703. https://doi.org/10.1136/gutjnl-2013-305635.Full Text Link to Item
-
Ford, Alexander C., Premysl Bercik, David G. Morgan, Carolina Bolino, Maria Ines Pintos-Sanchez, and Paul Moayyedi. “The Rome III criteria for the diagnosis of functional dyspepsia in secondary care are not superior to previous definitions.” Gastroenterology 146, no. 4 (April 2014): 932–40. https://doi.org/10.1053/j.gastro.2014.01.014.Full Text Link to Item
-
Williams, C. J. M., L. Peyrin-Biroulet, and A. C. Ford. “Systematic review with meta-analysis: malignancies with anti-tumour necrosis factor-α therapy in inflammatory bowel disease.” Aliment Pharmacol Ther 39, no. 5 (March 2014): 447–58. https://doi.org/10.1111/apt.12624.Full Text Link to Item
-
Bounford, E., and A. C. Ford. “Letter: effects of iron therapy after non-variceal acute upper gastrointestinal bleeding.” Aliment Pharmacol Ther 39, no. 3 (February 2014): 346. https://doi.org/10.1111/apt.12594.Full Text Link to Item
-
Ford, A. C., P. Bercik, D. G. Morgan, C. Bolino, M. I. Pintos-Sanchez, and P. Moayyedi. “Characteristics of functional bowel disorder patients: a cross-sectional survey using the Rome III criteria.” Aliment Pharmacol Ther 39, no. 3 (February 2014): 312–21. https://doi.org/10.1111/apt.12573.Full Text Link to Item
-
Shearer, Jessica, and Alexander C. Ford. “Polyethylene glycol in constipation-predominant irritable bowel syndrome.” Am J Gastroenterol 109, no. 1 (January 2014): 135. https://doi.org/10.1038/ajg.2013.389.Full Text Link to Item
-
Vidal, A. C., J. S. Smith, F. Valea, R. Bentley, M. Gradison, K. S. H. Yarnall, A. Ford, et al. “HPV genotypes and cervical intraepithelial Neoplasiain a multiethnic cohort in the southeastern United States.” Journal of Vaccines and Vaccination 5, no. 3 (January 1, 2014). https://doi.org/10.4172/2157-7560.1000224.Full Text
-
Vidal, A. C., J. S. Smith, F. Valea, R. Bentley, M. Gradison, K. S. H. Yarnall, A. Ford, et al. “HPV genotypes and cervical intraepithelial neoplasia in a multiethnic cohort in the southeastern USA.” Cancer Causes and Control 25, no. 8 (January 1, 2014): 1055–62. https://doi.org/10.1007/s10552-014-0406-2.Full Text
-
Yuan, Yuhong, Alex C. Ford, Khurram J. Khan, Javier P. Gisbert, David Forman, Grigorios I. Leontiadis, Frances Tse, et al. “Optimum duration of regimens for Helicobacter pylori eradication.” Cochrane Database Syst Rev, no. 12 (December 11, 2013): CD008337. https://doi.org/10.1002/14651858.CD008337.pub2.Full Text Link to Item
-
Billioud, Vincent, Alexander C. Ford, Emilie Del Tedesco, Jean-Frédéric Colombel, Xavier Roblin, and Laurent Peyrin-Biroulet. “Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis.” J Crohns Colitis 7, no. 11 (December 2013): 853–67. https://doi.org/10.1016/j.crohns.2013.01.014.Full Text Link to Item
-
Ford, Alexander C., Premysl Bercik, David G. Morgan, Carolina Bolino, Maria Ines Pintos-Sanchez, and Paul Moayyedi. “Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.” Gastroenterology 145, no. 6 (December 2013): 1262-70.e1. https://doi.org/10.1053/j.gastro.2013.08.048.Full Text Link to Item
-
Ford, Alexander C., and Nicholas J. Talley. “Response to Neis et al.” Am J Gastroenterol 108, no. 12 (December 2013): 1930. https://doi.org/10.1038/ajg.2013.338.Full Text Link to Item
-
Ford, Alexander C., and Paul Moayyedi. “Dyspepsia.” Curr Opin Gastroenterol 29, no. 6 (November 2013): 662–68. https://doi.org/10.1097/MOG.0b013e328365d45d.Full Text Link to Item
-
Sood, Ruchit, and Alexander C. Ford. “Linaclotide: new mechanisms and new promise for treatment in constipation and irritable bowel syndrome.” Ther Adv Chronic Dis 4, no. 6 (November 2013): 268–76. https://doi.org/10.1177/2040622313500110.Full Text Link to Item
-
Ford, Alexander C. “Death knell for placebo-controlled trials in chronic idiopathic constipation?” Gastroenterology 145, no. 4 (October 2013): 897–98. https://doi.org/10.1053/j.gastro.2013.08.032.Full Text Link to Item
-
Ford, Alexander C., Darren M. Brenner, and Philip S. Schoenfeld. “Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysis.” Am J Gastroenterol 108, no. 10 (October 2013): 1566–74. https://doi.org/10.1038/ajg.2013.169.Full Text Link to Item
-
Ansari, Saqib, and Alexander C. Ford. “Initial management of dyspepsia in primary care: an evidence-based approach.” Br J Gen Pract 63, no. 614 (September 2013): 498–99. https://doi.org/10.3399/bjgp13X671821.Full Text Link to Item
-
Ford, Alexander C., and Paul Moayyedi. “Dyspepsia.” Bmj 347 (August 29, 2013): f5059. https://doi.org/10.1136/bmj.f5059.Full Text Link to Item
-
Ford, Alexander C., and Laurent Peyrin-Biroulet. “Opportunistic infections with anti-tumor necrosis factor-α therapy in inflammatory bowel disease: meta-analysis of randomized controlled trials.” Am J Gastroenterol 108, no. 8 (August 2013): 1268–76. https://doi.org/10.1038/ajg.2013.138.Full Text Link to Item
-
Ford, Alexander C., Darren M. Brenner, and Philip S. Schoenfeld. “Don't forget about constipation with opioid treatment of chronic non-cancer pain.” Bmj 347 (July 16, 2013): f4492. https://doi.org/10.1136/bmj.f4492.Full Text Link to Item
-
Power, Andrew M., Nicholas J. Talley, and Alexander C. Ford. “Association between constipation and colorectal cancer: systematic review and meta-analysis of observational studies.” Am J Gastroenterol 108, no. 6 (June 2013): 894–903. https://doi.org/10.1038/ajg.2013.52.Full Text Link to Item
-
Eaden, James A., and Alexander Charles Ford. “Efficacy of granulocyte/monocyte apheresis for moderate to severe Crohn's disease.” Gut 62, no. 4 (April 2013): 653. https://doi.org/10.1136/gutjnl-2012-303660.Full Text Link to Item
-
Sainsbury, Anita, David S. Sanders, and Alexander C. Ford. “Prevalence of irritable bowel syndrome-type symptoms in patients with celiac disease: a meta-analysis.” Clin Gastroenterol Hepatol 11, no. 4 (April 2013): 359-65.e1. https://doi.org/10.1016/j.cgh.2012.11.033.Full Text Link to Item
-
Schoeman, Sarah A., Alison Cairns, and Alexander C. Ford. “A patient with chronic diarrhea of unknown cause.” Clin Gastroenterol Hepatol 11, no. 4 (April 2013): e27–28. https://doi.org/10.1016/j.cgh.2012.06.037.Full Text Link to Item
-
Ford, Alexander C. “First-line eradication therapy for Helicobacter pylori: time for a change?” Gastroenterology 144, no. 3 (March 2013): 652–53. https://doi.org/10.1053/j.gastro.2013.01.037.Full Text Link to Item
-
Halpin, Stephen J., P John Hamlin, Daniel P. Greer, Lisa Warren, and Alexander C. Ford. “Efficacy of infliximab in acute severe ulcerative colitis: a single-centre experience.” World J Gastroenterol 19, no. 7 (February 21, 2013): 1091–97. https://doi.org/10.3748/wjg.v19.i7.1091.Full Text Link to Item
-
Ford, Alexander C., Paul Moayyedi, and Steven B. Hanauer. “Ulcerative colitis.” Bmj 346 (February 5, 2013): f432. https://doi.org/10.1136/bmj.f432.Full Text Link to Item
-
Ford, A. C., D. Forman, A. G. Bailey, A. T. R. Axon, and P. Moayyedi. “The natural history of gastro-oesophageal reflux symptoms in the community and its effects on survival: a longitudinal 10-year follow-up study.” Aliment Pharmacol Ther 37, no. 3 (February 2013): 323–31. https://doi.org/10.1111/apt.12169.Full Text Link to Item
-
Asonganyi, Etienne, Meenakshi Vaghasia, Clarissa Rodrigues, Amruta Phadtare, Anne Ford, Ricardo Pietrobon, Julius Atashili, and Catherine Lynch. “Factors affecting compliance with clinical practice guidelines for pap smear screening among healthcare providers in africa: systematic review and meta-summary of 2045 individuals.” Plos One 8, no. 9 (2013): e72712. https://doi.org/10.1371/journal.pone.0072712.Full Text Link to Item
-
Lovell, Rebecca M., and Alexander C. Ford. “Reply to Machicado JD, Villafuerte-Galvez J, Marcos LA, Prevalence of irritable bowel syndrome in South America.” Clin Gastroenterol Hepatol 11, no. 1 (January 2013): 102–3. https://doi.org/10.1016/j.cgh.2012.10.007.Full Text Link to Item
-
Mayberry, J. F., A. Lobo, A. C. Ford, and A. Thomas. “NICE clinical guideline (CG152): the management of Crohn's disease in adults, children and young people.” Aliment Pharmacol Ther 37, no. 2 (January 2013): 195–203. https://doi.org/10.1111/apt.12102.Full Text Link to Item
-
Morais, S. A., and A. C. Ford. “Balancing risks and benefits of prucalopride for the treatment of chronic constipation in Asians.” Neurogastroenterol Motil 25, no. 1 (January 2013): 89. https://doi.org/10.1111/nmo.12026.Full Text Link to Item
-
Ford, Alexander C. “Acupuncture for irritable bowel syndrome.” Gastroenterology 143, no. 6 (December 2012): 1683–84. https://doi.org/10.1053/j.gastro.2012.10.006.Full Text Link to Item
-
Lovell, Rebecca M., and Alexander C. Ford. “Prevalence of gastro-esophageal reflux-type symptoms in individuals with irritable bowel syndrome in the community: a meta-analysis.” Am J Gastroenterol 107, no. 12 (December 2012): 1793–1801. https://doi.org/10.1038/ajg.2012.336.Full Text Link to Item
-
Gracie, D. J., J. S. Kane, S. Mumtaz, A. F. Scarsbrook, F. U. Chowdhury, and A. C. Ford. “Prevalence of, and predictors of, bile acid malabsorption in outpatients with chronic diarrhea.” Neurogastroenterol Motil 24, no. 11 (November 2012): 983-e538. https://doi.org/10.1111/j.1365-2982.2012.01953.x.Full Text Link to Item
-
Ford, Alexander C., and Nicholas J. Talley. “Laxatives for chronic constipation in adults.” Bmj 345 (October 1, 2012): e6168. https://doi.org/10.1136/bmj.e6168.Full Text Link to Item
-
Halpin, Stephen J., and Alexander C. Ford. “Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis.” Am J Gastroenterol 107, no. 10 (October 2012): 1474–82. https://doi.org/10.1038/ajg.2012.260.Full Text Link to Item
-
Ibarra-Drendall, C., M. M. Troch, W. T. Barry, G. Broadwater, E. F. Petricoin, J. Wulfkuhle, L. A. Liotta, et al. “Erratum: Pilot and feasibility study: Prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways (Breast Cancer Research and Treatment (2012) 132 (487-498) DOI: 10.1007/s10549-011-1609-9).” Breast Cancer Research and Treatment 135, no. 3 (October 1, 2012): 925. https://doi.org/10.1007/s10549-012-2227-x.Full Text
-
Ford, Alexander C., and Nicholas J. Talley. “Irritable bowel syndrome.” Bmj 345 (September 4, 2012): e5836. https://doi.org/10.1136/bmj.e5836.Full Text Link to Item
-
Whitehouse, Heather J., and Alexander C. Ford. “Direction of the brain--gut pathway in functional gastrointestinal disorders.” Gut 61, no. 9 (September 2012): 1368. https://doi.org/10.1136/gutjnl-2012-302228.Full Text Link to Item
-
Ford, Alexander C. “In irritable bowel syndrome, antispasmodics and antidepressants improve abdominal pain and global assessment and symptom scores, but there is no evidence for the effectiveness of bulking agents.” Evid Based Med 17, no. 4 (August 2012): 114–15. https://doi.org/10.1136/ebmed-2011-100424.Full Text Link to Item
-
Kennedy, M., and A. C. Ford. “Letter: the effects of overlapping symptoms on the response to PPI therapy in GERD.” Aliment Pharmacol Ther 36, no. 2 (July 2012): 207. https://doi.org/10.1111/j.1365-2036.2012.05138.x.Full Text Link to Item
-
Lovell, Rebecca M., and Alexander C. Ford. “Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis.” Clin Gastroenterol Hepatol 10, no. 7 (July 2012): 712-721.e4. https://doi.org/10.1016/j.cgh.2012.02.029.Full Text Link to Item
-
Lovell, Rebecca M., and Alexander C. Ford. “Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis.” Am J Gastroenterol 107, no. 7 (July 2012): 991–1000. https://doi.org/10.1038/ajg.2012.131.Full Text Link to Item
-
Ford, Alexander C. “Eradicating Helicobacter pylori in functional dyspepsia.” Gastroenterology 142, no. 7 (June 2012): 1613–14. https://doi.org/10.1053/j.gastro.2012.04.022.Full Text Link to Item
-
Ford, Alexander C., David Forman, Alastair G. Bailey, Anthony T. R. Axon, and Paul Moayyedi. “Effect of dyspepsia on survival: a longitudinal 10-year follow-up study.” Am J Gastroenterol 107, no. 6 (June 2012): 912–21. https://doi.org/10.1038/ajg.2012.69.Full Text Link to Item
-
Ford, Alexander C., Khurram J. Khan, William J. Sandborn, Stephen B. Hanauer, and Paul Moayyedi. “Efficacy of topical 5-aminosalicylates in preventing relapse of quiescent ulcerative colitis: a meta-analysis.” Clin Gastroenterol Hepatol 10, no. 5 (May 2012): 513–19. https://doi.org/10.1016/j.cgh.2011.10.043.Full Text Link to Item
-
Ibarra-Drendall, Catherine, Michelle M. Troch, William T. Barry, Gloria Broadwater, Emanuel F. Petricoin, Julia Wulfkuhle, Lance A. Liotta, et al. “Pilot and feasibility study: prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways.” Breast Cancer Res Treat 132, no. 2 (April 2012): 487–98. https://doi.org/10.1007/s10549-011-1609-9.Full Text Link to Item
-
Sprakes, Michael B., Alexander C. Ford, Lisa Warren, Dan Greer, and John Hamlin. “Efficacy, tolerability, and predictors of response to infliximab therapy for Crohn's disease: a large single centre experience.” J Crohns Colitis 6, no. 2 (March 2012): 143–53. https://doi.org/10.1016/j.crohns.2011.07.011.Full Text Link to Item
-
Slater, Claire M., and Alexander C. Ford. “Treatment of Helicobacter pylori in Latin America.” Lancet 379, no. 9814 (February 4, 2012): 407. https://doi.org/10.1016/S0140-6736(12)60180-9.Full Text Link to Item
-
Farquharson, A. L., A. Chopra, A. Ford, S. Matthews, S. N. Amin, and R. De Noronha. “Incidental focal colonic lesions found on (18)Fluorodeoxyglucose positron emission tomography/computed tomography scan: further support for a national guideline on definitive management.” Colorectal Dis 14, no. 2 (February 2012): e56–63. https://doi.org/10.1111/j.1463-1318.2011.02760.x.Full Text Link to Item
-
Ford, Alexander C., Khurram J. Khan, Jean-Paul Achkar, and Paul Moayyedi. “Efficacy of oral vs. topical, or combined oral and topical 5-aminosalicylates, in Ulcerative Colitis: systematic review and meta-analysis.” Am J Gastroenterol 107, no. 2 (February 2012): 167–76. https://doi.org/10.1038/ajg.2011.410.Full Text Link to Item
-
Suares, N. C., P. J. Hamlin, D. P. Greer, L. Warren, T. Clark, and A. C. Ford. “Efficacy and tolerability of methotrexate therapy for refractory Crohn's disease: a large single-centre experience.” Aliment Pharmacol Ther 35, no. 2 (January 2012): 284–91. https://doi.org/10.1111/j.1365-2036.2011.04925.x.Full Text Link to Item
-
Ford, Alexander C., Khurram J. Khan, William J. Sandborn, Sunanda V. Kane, and Paul Moayyedi. “Once-daily dosing vs. conventional dosing schedule of mesalamine and relapse of quiescent ulcerative colitis: systematic review and meta-analysis.” Am J Gastroenterol 106, no. 12 (December 2011): 2070–77. https://doi.org/10.1038/ajg.2011.296.Full Text Link to Item
-
Desborough, M. J., and A. C. Ford. “Is otilonium bromide globally effective in irritable bowel syndrome?” Aliment Pharmacol Ther 34, no. 8 (October 2011): 1034–35. https://doi.org/10.1111/j.1365-2036.2011.04769.x.Full Text Link to Item
-
Mumtaz, Saqib, and Alexander C. Ford. “Losses to follow-up limit conclusions regarding the efficacy of branched-chain amino acids in patients with hepatic encephalopathy.” Am J Gastroenterol 106, no. 9 (September 2011): 1718. https://doi.org/10.1038/ajg.2011.221.Full Text Link to Item
-
Suares, Nicole C., and Alexander C. Ford. “Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis.” Am J Gastroenterol 106, no. 9 (September 2011): 1582–91. https://doi.org/10.1038/ajg.2011.164.Full Text Link to Item
-
Ford, Alexander C. “Chemoprevention for gastric cancer.” Best Pract Res Clin Gastroenterol 25, no. 4–5 (August 2011): 581–92. https://doi.org/10.1016/j.bpg.2011.09.002.Full Text Link to Item
-
Sprakes, Michael B., P John Hamlin, Lisa Warren, Dan Greer, and Alexander C. Ford. “Adalimumab as second line anti-tumour necrosis factor alpha therapy for Crohn's disease: A single centre experience.” J Crohns Colitis 5, no. 4 (August 2011): 324–31. https://doi.org/10.1016/j.crohns.2011.02.007.Full Text Link to Item
-
Pawar, Priya N., and Alexander C. Ford. “Helicobacter pylori eradication.” Lancet 378, no. 9788 (July 23, 2011): 313. https://doi.org/10.1016/S0140-6736(11)61159-8.Full Text Link to Item
-
Ford, A. C., N. C. Suares, and N. J. Talley. “Meta-analysis: the epidemiology of noncardiac chest pain in the community.” Aliment Pharmacol Ther 34, no. 2 (July 2011): 172–80. https://doi.org/10.1111/j.1365-2036.2011.04702.x.Full Text Link to Item
-
Sainsbury, A., D. S. Sanders, and A. C. Ford. “Meta-analysis: Coeliac disease and hypertransaminasaemia.” Aliment Pharmacol Ther 34, no. 1 (July 2011): 33–40. https://doi.org/10.1111/j.1365-2036.2011.04685.x.Full Text Link to Item
-
Lau, S., C. F. Donnellan, and A. C. Ford. “Do dried plums really help constipation?” Aliment Pharmacol Ther 33, no. 11 (June 2011): 1258–59. https://doi.org/10.1111/j.1365-2036.2011.04649.x.Full Text Link to Item
-
Whiting, Rebecca L., and Alexander C. Ford. “Efficacy of traditional chinese medicine in functional constipation.” Am J Gastroenterol 106, no. 5 (May 2011): 1003. https://doi.org/10.1038/ajg.2011.14.Full Text Link to Item
-
Ford, Alexander C., Charles N. Bernstein, Khurram J. Khan, Maria T. Abreu, John K. Marshall, Nicholas J. Talley, and Paul Moayyedi. “Glucocorticosteroid therapy in inflammatory bowel disease: systematic review and meta-analysis.” Am J Gastroenterol 106, no. 4 (April 2011): 590–99. https://doi.org/10.1038/ajg.2011.70.Full Text Link to Item
-
Ford, Alexander C., Jean-Paul Achkar, Khurram J. Khan, Sunanda V. Kane, Nicholas J. Talley, John K. Marshall, and Paul Moayyedi. “Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis.” Am J Gastroenterol 106, no. 4 (April 2011): 601–16. https://doi.org/10.1038/ajg.2011.67.Full Text Link to Item
-
Ford, Alexander C., Sunanda V. Kane, Khurram J. Khan, Jean-Paul Achkar, Nicholas J. Talley, John K. Marshall, and Paul Moayyedi. “Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis.” Am J Gastroenterol 106, no. 4 (April 2011): 617–29. https://doi.org/10.1038/ajg.2011.71.Full Text Link to Item
-
Ford, Alexander C., William J. Sandborn, Khurram J. Khan, Stephen B. Hanauer, Nicholas J. Talley, and Paul Moayyedi. “Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis.” Am J Gastroenterol 106, no. 4 (April 2011): 644–60. https://doi.org/10.1038/ajg.2011.73.Full Text Link to Item
-
Ford, Alexander C., and Nicholas J. Talley. “Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review.” J Gastroenterol 46, no. 4 (April 2011): 421–31. https://doi.org/10.1007/s00535-011-0379-9.Full Text Link to Item
-
Khan, Khurram J., Marla C. Dubinsky, Alexander C. Ford, Thomas A. Ullman, Nicholas J. Talley, and Paul Moayyedi. “Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis.” Am J Gastroenterol 106, no. 4 (April 2011): 630–42. https://doi.org/10.1038/ajg.2011.64.Full Text Link to Item
-
Khan, Khurram J., Thomas A. Ullman, Alexander C. Ford, Maria T. Abreu, Amir Abadir, John K. Marshall, Nicholas J. Talley, and Paul Moayyedi. “Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis.” Am J Gastroenterol 106, no. 4 (April 2011): 661–73. https://doi.org/10.1038/ajg.2011.72.Full Text Link to Item
-
Suares, N. C., and A. C. Ford. “Systematic review: the effects of fibre in the management of chronic idiopathic constipation.” Aliment Pharmacol Ther 33, no. 8 (April 2011): 895–901. https://doi.org/10.1111/j.1365-2036.2011.04602.x.Full Text Link to Item
-
Ford, Alexander C., Khurram J. Khan, Nicholas J. Talley, and Paul Moayyedi. “5-aminosalicylates prevent relapse of Crohn's disease after surgically induced remission: systematic review and meta-analysis.” Am J Gastroenterol 106, no. 3 (March 2011): 413–20. https://doi.org/10.1038/ajg.2010.317.Full Text Link to Item
-
Jackson, Emma L., P John Hamlin, and Alexander C. Ford. “VSL#3 and remission in active ulcerative colitis: larger studies required.” Am J Gastroenterol 106, no. 3 (March 2011): 547. https://doi.org/10.1038/ajg.2010.451.Full Text Link to Item
-
Moayyedi, Paul, and Alexander C. Ford. “Symptom-based diagnostic criteria for irritable bowel syndrome: the more things change, the more they stay the same.” Gastroenterol Clin North Am 40, no. 1 (March 2011): 87–103. https://doi.org/10.1016/j.gtc.2010.12.007.Full Text Link to Item
-
Pilie, Patrick G., Catherine Ibarra-Drendall, Michelle M. Troch, Gloria Broadwater, William T. Barry, Emanuel F. Petricoin, Julia D. Wulfkuhle, et al. “Protein microarray analysis of mammary epithelial cells from obese and nonobese women at high risk for breast cancer: feasibility data.” Cancer Epidemiol Biomarkers Prev 20, no. 3 (March 2011): 476–82. https://doi.org/10.1158/1055-9965.EPI-10-0847.Full Text Link to Item
-
Sainsbury, Anita, and Alexander C. Ford. “Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents.” Therap Adv Gastroenterol 4, no. 2 (March 2011): 115–27. https://doi.org/10.1177/1756283X10387203.Full Text Link to Item
-
Ford, Alexander C., and Nicholas J. Talley. “IBS in 2010: advances in pathophysiology, diagnosis and treatment.” Nat Rev Gastroenterol Hepatol 8, no. 2 (February 2011): 76–78. https://doi.org/10.1038/nrgastro.2010.216.Full Text Link to Item
-
Ford, Alexander C., and Nicole C. Suares. “Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis.” Gut 60, no. 2 (February 2011): 209–18. https://doi.org/10.1136/gut.2010.227132.Full Text Link to Item
-
Raja, S., and A. C. Ford. “Defining a responder in treatment trials for chronic idiopathic constipation.” Aliment Pharmacol Ther 33, no. 2 (January 2011): 285–86. https://doi.org/10.1111/j.1365-2036.2010.04504.x.Full Text Link to Item
-
Sprakes, Michael B., P John Hamlin, and Alexander C. Ford. “Utility of fecal calprotectin in differentiating active inflammatory bowel disease from coexistent irritable bowel syndrome.” Am J Gastroenterol 106, no. 1 (January 2011): 166. https://doi.org/10.1038/ajg.2010.355.Full Text Link to Item
-
Coughlan, J., P. J. Hamlin, and A. C. Ford. “Effect of oral zinc in hepatic encephalopathy remains unclear.” Aliment Pharmacol Ther 32, no. 11–12 (December 2010): 1405–6. https://doi.org/10.1111/j.1365-2036.2010.04483.x.Full Text Link to Item
-
Ford, Alexander C. “Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease.” Gut 59, no. 12 (December 2010): 1731–32. https://doi.org/10.1136/gut.2010.218941.Full Text Link to Item
-
Sprakes, M. B., A. C. Ford, N. C. Suares, L. Warren, D. Greer, C. F. Donnellan, J. S. R. Jennings, S. M. Everett, and P. J. Hamlin. “Costs of care for Crohn's disease following the introduction of infliximab: a single-centre UK experience.” Aliment Pharmacol Ther 32, no. 11–12 (December 2010): 1357–63. https://doi.org/10.1111/j.1365-2036.2010.04482.x.Full Text Link to Item
-
Thanaraj, S., P. J. Hamlin, and A. C. Ford. “Systematic review: granulocyte/monocyte adsorptive apheresis for ulcerative colitis.” Aliment Pharmacol Ther 32, no. 11–12 (December 2010): 1297–1306. https://doi.org/10.1111/j.1365-2036.2010.04490.x.Full Text Link to Item
-
Ford, A. C. “Low yield of colonoscopy in individuals with suspected irritable bowel syndrome?” Am J Gastroenterol 105, no. 11 (November 2010): 2508–9. https://doi.org/10.1038/ajg.2010.267.Full Text Link to Item
-
Ford, A. C. “Reporting of relapse rates in a trial of mesalazine for ulcerative colitis.” Aliment Pharmacol Ther 32, no. 9 (November 2010): 1205–6. https://doi.org/10.1111/j.1365-2036.2010.04451.x.Full Text Link to Item
-
Ford, Alexander C. “Overlap among the functional gastrointestinal disorders.” Am J Gastroenterol 105, no. 11 (November 2010): 2512. https://doi.org/10.1038/ajg.2010.353.Full Text Link to Item
-
Halpin, S. J., P. J. Hamlin, and A. C. Ford. “Infliximab rescue therapy in ulcerative colitis, and the effect on subsequent colectomy rates.” Aliment Pharmacol Ther 32, no. 10 (November 2010): 1294–95. https://doi.org/10.1111/j.1365-2036.2010.04478.x.Full Text Link to Item
-
Ford, Alexander C., Avantika Marwaha, Allen Lim, and Paul Moayyedi. “What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsia? Systematic review and meta-analysis.” Clin Gastroenterol Hepatol 8, no. 10 (October 2010): 830-837.e2. https://doi.org/10.1016/j.cgh.2010.05.031.Full Text Link to Item
-
Ford, Alexander C., and Anthony T. R. Axon. “Epidemiology of Helicobacter pylori infection and public health implications.” Helicobacter 15 Suppl 1 (September 2010): 1–6. https://doi.org/10.1111/j.1523-5378.2010.00779.x.Full Text Link to Item
-
Ford, A. C. “Dyspepsia and irritable bowel syndrome: mutually exclusive conditions?” Aliment Pharmacol Ther 32, no. 4 (August 2010): 612–13. https://doi.org/10.1111/j.1365-2036.2010.04384.x.Full Text Link to Item
-
Ford, Alexander C. “Breath testing and antibiotics for possible bacterial overgrowth in irritable bowel syndrome.” Expert Rev Anti Infect Ther 8, no. 8 (August 2010): 855–57. https://doi.org/10.1586/eri.10.66.Full Text Link to Item
-
Ford, A. C. “Renzapride in IBS: is efficacy in the eye of the beholder?” Aliment Pharmacol Ther 32, no. 1 (July 2010): 113–14. https://doi.org/10.1111/j.1365-2036.2010.04275.x.Full Text Link to Item
-
Ford, A. C., and P. Moayyedi. “Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome.” Aliment Pharmacol Ther 32, no. 2 (July 2010): 144–58. https://doi.org/10.1111/j.1365-2036.2010.04328.x.Full Text Link to Item
-
Thanaraj, Sangeetha, P John Hamlin, and Alexander C. Ford. “Is the benefit of granulocyte monocyte adsorptive apheresis in ulcerative colitis overstated?” Dig Dis Sci 55, no. 6 (June 2010): 1803. https://doi.org/10.1007/s10620-010-1188-3.Full Text Link to Item
-
Ghosh, Tilak, Alexander C. Ford, and Simon Everett. “Disease activity and venous thromboembolism in inflammatory bowel disease.” Lancet 375, no. 9727 (May 15, 2010): 1690. https://doi.org/10.1016/S0140-6736(10)60729-5.Full Text Link to Item
-
Craig, D. G. N., A. C. Ford, P. C. Hayes, and K. J. Simpson. “Systematic review: prognostic tests of paracetamol-induced acute liver failure.” Aliment Pharmacol Ther 31, no. 10 (May 2010): 1064–76. https://doi.org/10.1111/j.1365-2036.2010.04279.x.Full Text Link to Item
-
Ford, Alexander C., Avantika Marwaha, Allen Lim, and Paul Moayyedi. “Systematic review and meta-analysis of the prevalence of irritable bowel syndrome in individuals with dyspepsia.” Clin Gastroenterol Hepatol 8, no. 5 (May 2010): 401–9. https://doi.org/10.1016/j.cgh.2009.07.020.Full Text Link to Item
-
Ford, Alexander C., Marroon Thabane, Stephen M. Collins, Paul Moayyedi, Amit X. Garg, William F. Clark, and John K. Marshall. “Prevalence of uninvestigated dyspepsia 8 years after a large waterborne outbreak of bacterial dysentery: a cohort study.” Gastroenterology 138, no. 5 (May 2010): 1727–36. https://doi.org/10.1053/j.gastro.2010.01.043.Full Text Link to Item
-
Ford, A. C. “Alverine citrate, simeticone, and Rome III irritable bowel syndrome.” Aliment Pharmacol Ther 31, no. 7 (April 2010): 767–68. https://doi.org/10.1111/j.1365-2036.2009.04222.x.Full Text Link to Item
-
Ford, A. C. “Probiotics in irritable bowel syndrome: underachievers or underpowered?” Aliment Pharmacol Ther 31, no. 8 (April 2010): 922–23. https://doi.org/10.1111/j.1365-2036.2009.04223.x.Full Text Link to Item
-
Ford, Alexander C., and Paul Moayyedi. “"Power" of selective serotonin reuptake inhibitors in irritable bowel syndrome.” Clin Gastroenterol Hepatol 8, no. 3 (March 2010): 313–14. https://doi.org/10.1016/j.cgh.2009.10.027.Full Text Link to Item
-
Moayyedi, P., A. C. Ford, N. J. Talley, F. Cremonini, A. E. Foxx-Orenstein, L. J. Brandt, and E. M. M. Quigley. “The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review.” Gut 59, no. 3 (March 2010): 325–32. https://doi.org/10.1136/gut.2008.167270.Full Text Link to Item
-
Ford, Alexander C., Gordon H. Guyatt, Nicholas J. Talley, and Paul Moayyedi. “Errors in the conduct of systematic reviews of pharmacological interventions for irritable bowel syndrome.” Am J Gastroenterol 105, no. 2 (February 2010): 280–88. https://doi.org/10.1038/ajg.2009.658.Full Text Link to Item
-
Moayyedi, Paul, Alexander C. Ford, Eamonn M. M. Quigley, Amy E. Foxx-Orenstein, William D. Chey, Nicholas J. Talley, and Lawrence J. Brandt. “The American College of Gastroenterology irritable bowel syndrome monograph: translating systematic review data to clinical practice.” Gastroenterology 138, no. 2 (February 2010): 789–91. https://doi.org/10.1053/j.gastro.2009.09.077.Full Text Link to Item
-
Ford, A. C. “Applicability of the reported prevalence of bile salt malabsorption in irritable bowel.” Aliment Pharmacol Ther 31, no. 1 (January 2010): 161–62. https://doi.org/10.1111/j.1365-2036.2009.04155.x.Full Text Link to Item
-
Ford, Alexander C. “GERD: Is laparoscopic surgery cost-effective?” Nat Rev Gastroenterol Hepatol 6, no. 12 (December 2009): 695–96. https://doi.org/10.1038/nrgastro.2009.196.Full Text Link to Item
-
Ford, Alexander C., Brennan M. R. Spiegel, Nicholas J. Talley, and Paul Moayyedi. “Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis.” Clin Gastroenterol Hepatol 7, no. 12 (December 2009): 1279–86. https://doi.org/10.1016/j.cgh.2009.06.031.Full Text Link to Item
-
Ford, A. C. “Generalized anxiety disorder and irritable bowel syndrome.” Aliment Pharmacol Ther 30, no. 10 (November 15, 2009): 1087–88. https://doi.org/10.1111/j.1365-2036.2009.04127.x.Full Text Link to Item
-
Delaney, Brendan, Alex C. Ford, David Forman, Paul Moayyedi, and Michelle Qume. “WITHDRAWN: Initial management strategies for dyspepsia.” Cochrane Database Syst Rev, no. 4 (October 7, 2009): CD001961. https://doi.org/10.1002/14651858.CD001961.pub3.Full Text Link to Item
-
Ford, Alexander C., and Paul Moayyedi. “Redundant data in the meta-analysis on Helicobacter pylori eradication.” Ann Intern Med 151, no. 7 (October 6, 2009): 513. https://doi.org/10.7326/0003-4819-151-7-200910060-00014.Full Text Link to Item
-
Ford, Alexander C., Nicholas J. Talley, Eamonn M. M. Quigley, and Paul Moayyedi. “Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials.” Dis Colon Rectum 52, no. 10 (October 2009): 1805. https://doi.org/10.1007/DCR.0b013e3181ae0ab8.Full Text Link to Item
-
Ford, Alexander C., and Paul Moayyedi. “Bran and irritable bowels. Bran's deleterious effects: much ado about nothing.” Bmj 339 (September 29, 2009): b3956. https://doi.org/10.1136/bmj.b3956.Full Text Link to Item
-
Ford, Alexander C., and Nicholas J. Talley. “Does Helicobacter pylori really cause duodenal ulcers? Yes.” Bmj 339 (August 14, 2009): b2784. https://doi.org/10.1136/bmj.b2784.Full Text Link to Item
-
Ford, Alexander C., and Paul Moayyedi. “Managing dyspepsia.” Curr Gastroenterol Rep 11, no. 4 (August 2009): 288–94. https://doi.org/10.1007/s11894-009-0042-2.Full Text Link to Item
-
Ford, Alexander C., and Paul Moayyedi. “Treatment of chronic gastro-oesophageal reflux disease.” Bmj 339 (July 14, 2009): b2481. https://doi.org/10.1136/bmj.b2481.Full Text Link to Item
-
Ford, A. C., E. Ching, and P. Moayyedi. “Meta-analysis: yield of diagnostic tests for coeliac disease in dyspepsia.” Aliment Pharmacol Ther 30, no. 1 (July 2009): 28–36. https://doi.org/10.1111/j.1365-2036.2009.04008.x.Full Text Link to Item
-
Ford, A. C., N. J. Talley, and P. Moayyedi. “10-biomarker algorithm to identify irritable bowel syndrome.” Aliment Pharmacol Ther 30, no. 1 (July 2009): 95–96. https://doi.org/10.1111/j.1365-2036.2009.04007.x.Full Text Link to Item
-
Ford, Alexander C., Lawrence J. Brandt, Christine Young, William D. Chey, Amy E. Foxx-Orenstein, and Paul Moayyedi. “Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis.” Am J Gastroenterol 104, no. 7 (July 2009): 1831–43. https://doi.org/10.1038/ajg.2009.223.Full Text Link to Item
-
Ford, Alexander C., William D. Chey, Nicholas J. Talley, Ashish Malhotra, Brennan M. R. Spiegel, and Paul Moayyedi. “Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis.” Arch Intern Med 169, no. 7 (April 13, 2009): 651–58. https://doi.org/10.1001/archinternmed.2009.22.Full Text Link to Item
-
Ford, A. C., N. J. Talley, P. S. Schoenfeld, E. M. M. Quigley, and P. Moayyedi. “Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis.” Gut 58, no. 3 (March 2009): 367–78. https://doi.org/10.1136/gut.2008.163162.Full Text Link to Item
-
Ford, Alexander C., Peter Malfertheiner, Monique Giguere, Jose Santana, Mostafizur Khan, and Paul Moayyedi. “Adverse events with bismuth salts for Helicobacter pylori eradication: systematic review and meta-analysis.” World J Gastroenterol 14, no. 48 (December 28, 2008): 7361–70. https://doi.org/10.3748/wjg.14.7361.Full Text Link to Item
-
Ford, Alexander C., Nicholas J. Talley, Brennan M. R. Spiegel, Amy E. Foxx-Orenstein, Lawrence Schiller, Eamonn M. M. Quigley, and Paul Moayyedi. “Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis.” Bmj 337 (November 13, 2008): a2313. https://doi.org/10.1136/bmj.a2313.Full Text Link to Item
-
Ford, A. C., S. J. O. Veldhuyzen van Zanten, C. C. Rodgers, N. J. Talley, N. B. Vakil, and P. Moayyedi. “Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis.” Gut 57, no. 11 (November 2008): 1545–53. https://doi.org/10.1136/gut.2008.159723.Full Text Link to Item
-
Ford, A. C., D. Forman, A. G. Bailey, A. T. R. Axon, and P. Moayyedi. “Fluctuation of gastrointestinal symptoms in the community: a 10-year longitudinal follow-up study.” Aliment Pharmacol Ther 28, no. 8 (October 15, 2008): 1013–20. https://doi.org/10.1111/j.1365-2036.2008.03813.x.Full Text Link to Item
-
Ford, Alexander C., Nicholas J. Talley, Sander J. O. Veldhuyzen van Zanten, Nimish B. Vakil, David L. Simel, and Paul Moayyedi. “Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms?” Jama 300, no. 15 (October 15, 2008): 1793–1805. https://doi.org/10.1001/jama.300.15.1793.Full Text Link to Item
-
Ford, A. C., P. Moayyedi, D. E. Jarbol, R. F. A. Logan, and B. C. Delaney. “Meta-analysis: Helicobacter pylori'test and treat' compared with empirical acid suppression for managing dyspepsia.” Aliment Pharmacol Ther 28, no. 5 (September 1, 2008): 534–44. https://doi.org/10.1111/j.1365-2036.2008.03784.x.Full Text Link to Item
-
Watts, Victoria, Alex Ford, Alex Brown, and S. Moreea. “Balancing the risk of chronic gastrointestinal bleeding and thromboembolic events in a patient with a metallic aortic valve.” Clin Med (Lond) 8, no. 4 (August 2008): 461–62. https://doi.org/10.7861/clinmedicine.8-4-461.Full Text Link to Item
-
Ford, Alexander C., David Forman, Alastair G. Bailey, Anthony T. R. Axon, and Paul Moayyedi. “Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior.” Am J Gastroenterol 103, no. 5 (May 2008): 1229–39. https://doi.org/10.1111/j.1572-0241.2007.01740.x.Full Text Link to Item
-
Delaney, Brendan C., Michelle Qume, Paul Moayyedi, Richard F. A. Logan, Alexander C. Ford, Cathy Elliott, Cliodna McNulty, Sue Wilson, and FD Richard Hobbs. “Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial).” Bmj 336, no. 7645 (March 22, 2008): 651–54. https://doi.org/10.1136/bmj.39479.640486.AE.Full Text Link to Item
-
Ford, Alexander C., and Paul Moayyedi. “Current guidelines for dyspepsia management.” Dig Dis 26, no. 3 (2008): 225–30. https://doi.org/10.1159/000121351.Full Text Link to Item
-
Ford, Alexander C., David Forman, Alastair G. Bailey, Karen J. Goodman, Anthony T. R. Axon, and Paul Moayyedi. “Effect of sibling number in the household and birth order on prevalence of Helicobacter pylori: a cross-sectional study.” Int J Epidemiol 36, no. 6 (December 2007): 1327–33. https://doi.org/10.1093/ije/dym201.Full Text Link to Item
-
Palaniappan, S., A. C. Ford, D. Greer, S. M. Everett, D. M. Chalmers, A. T. R. Axon, and P. J. Hamlin. “Mycophenolate mofetil therapy for refractory inflammatory bowel disease.” Inflamm Bowel Dis 13, no. 12 (December 2007): 1488–92. https://doi.org/10.1002/ibd.20258.Full Text Link to Item
-
Ford, A. C., D. Forman, J. Nathan, W. D. Crocombe, A. T. R. Axon, and P. Moayyedi. “Clinical trial: knowledge of negative Helicobacter pylori status reduces subsequent dyspepsia-related resource use.” Aliment Pharmacol Ther 26, no. 9 (November 1, 2007): 1267–75. https://doi.org/10.1111/j.1365-2036.2007.03500.x.Full Text Link to Item
-
Ford, Alexander C., David Forman, Alastair G. Bailey, Michael B. Cook, Anthony T. R. Axon, and Paul Moayyedi. “Who consults with dyspepsia? Results from a longitudinal 10-yr follow-up study.” Am J Gastroenterol 102, no. 5 (May 2007): 957–65. https://doi.org/10.1111/j.1572-0241.2007.01080.x.Full Text Link to Item
-
Ford, Alexander C., David Forman, Alastair G. Bailey, Anthony T. R. Axon, and Paul Moayyedi. “Initial poor quality of life and new onset of dyspepsia: results from a longitudinal 10-year follow-up study.” Gut 56, no. 3 (March 2007): 321–27. https://doi.org/10.1136/gut.2006.099846.Full Text Link to Item
-
Fraser, A., B. C. Delaney, A. C. Ford, M. Qume, and P. Moayyedi. “The Short-Form Leeds Dyspepsia Questionnaire validation study.” Aliment Pharmacol Ther 25, no. 4 (February 15, 2007): 477–86. https://doi.org/10.1111/j.1365-2036.2006.03233.x.Full Text Link to Item
-
Ford, A. C., D. Forman, P. Moayyedi, and A. H. Morice. “Cough in the community: a cross sectional survey and the relationship to gastrointestinal symptoms.” Thorax 61, no. 11 (November 2006): 975–79. https://doi.org/10.1136/thx.2006.060087.Full Text Link to Item
-
Ford, A. C., B. C. Delaney, D. Forman, and P. Moayyedi. “Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients.” Cochrane Database Syst Rev, no. 2 (April 19, 2006): CD003840. https://doi.org/10.1002/14651858.CD003840.pub4.Full Text Link to Item
-
Ford, Alexander C., David Forman, Alastair G. Bailey, Anthony T. R. Axon, and Paul Moayyedi. “A community screening program for Helicobacter pylori saves money: 10-year follow-up of a randomized controlled trial.” Gastroenterology 129, no. 6 (December 2005): 1910–17. https://doi.org/10.1053/j.gastro.2005.09.016.Full Text Link to Item
-
Delaney, B., A. C. Ford, D. Forman, P. Moayyedi, and M. Qume. “Initial management strategies for dyspepsia.” Cochrane Database Syst Rev, no. 4 (October 19, 2005): CD001961. https://doi.org/10.1002/14651858.CD001961.pub2.Full Text Link to Item
-
Ford, Alexander C., Alan G. Chalmers, and P John Hamlin. “Image of the month. Autoimmune pancreatitis.” Gastroenterology 129, no. 3 (September 2005): 785–1141. https://doi.org/10.1053/j.gastro.2005.07.048.Full Text Link to Item
-
Ford, Alexander C., David Forman, P Dominic Reynolds, Brian T. Cooper, and Paul Moayyedi. “Ethnicity, gender, and socioeconomic status as risk factors for esophagitis and Barrett's esophagus.” Am J Epidemiol 162, no. 5 (September 1, 2005): 454–60. https://doi.org/10.1093/aje/kwi218.Full Text Link to Item
-
Mahadeva, S., M. C. Raman, A. C. Ford, M. Follows, A. T. R. Axon, K. -. L. Goh, and P. Moayyedi. “Gastro-oesophageal reflux is more prevalent in Western dyspeptics: a prospective comparison of British and South-East Asian patients with dyspepsia.” Aliment Pharmacol Ther 21, no. 12 (June 15, 2005): 1483–90. https://doi.org/10.1111/j.1365-2036.2005.02455.x.Full Text Link to Item
-
Ford, Alexander C., Michelle Qume, Paul Moayyedi, Nicolaas L. A. Arents, Annmarie T. Lassen, Richard F. A. Logan, Kenneth E. L. McColl, Paul Myres, and Brendan C. Delaney. “Helicobacter pylori "test and treat" or endoscopy for managing dyspepsia: an individual patient data meta-analysis.” Gastroenterology 128, no. 7 (June 2005): 1838–44. https://doi.org/10.1053/j.gastro.2005.03.004.Full Text Link to Item
-
Ford, Alexander C., Brendan C. Delaney, David Forman, and Paul Moayyedi. “Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis.” Am J Gastroenterol 99, no. 9 (September 2004): 1833–55. https://doi.org/10.1111/j.1572-0241.2004.40014.x.Full Text Link to Item
-
Ford, A. C., R. J. Towler, P. Moayyedi, D. M. Chalmers, and A. T. R. Axon. “Mycophenolate mofetil in refractory inflammatory bowel disease.” Aliment Pharmacol Ther 17, no. 11 (June 1, 2003): 1365–69. https://doi.org/10.1046/j.1365-2036.2003.01581.x.Full Text Link to Item
-
Moayyedi, Paul, and Alex Ford. “Recent developments in gastroenterology.” Bmj 325, no. 7377 (December 14, 2002): 1399–1402. https://doi.org/10.1136/bmj.325.7377.1399.Full Text Link to Item
-
Ford, Alexander C., Joanne Ridpath, and Douglas Chalmers. “Hemobiliary from arterial pseudoaneurysm.” Gastroenterology 122, no. 7 (June 2002): 1720–2098. https://doi.org/10.1053/gast.2002.34099.Full Text Link to Item
-
Couper, R., R. Byard, and A. Ford. “Maternal diarrhea and ischemic enteritis in newborn twins: possible association with an hemolytic uremic syndrome outbreak.” J Pediatr Gastroenterol Nutr 25, no. 3 (September 1997): 366. https://doi.org/10.1097/00005176-199709000-00024.Full Text Link to Item
-
Bergwerk, A. J., X. Shi, A. C. Ford, N. Kanai, E. Jacquemin, R. D. Burk, S. Bai, et al. “Immunologic distribution of an organic anion transport protein in rat liver and kidney.” Am J Physiol 271, no. 2 Pt 1 (August 1996): G231–38. https://doi.org/10.1152/ajpgi.1996.271.2.G231.Full Text Link to Item
-
Cooke, R. J., A. Ford, S. Werkman, C. Conner, and D. Watson. “Postnatal growth in infants born between 700 and 1,500 g.” J Pediatr Gastroenterol Nutr 16, no. 2 (February 1993): 130–35. https://doi.org/10.1097/00005176-199302000-00006.Full Text Link to Item
-
-
Conference Papers
-
Venerito, Marino, Alexander C. Ford, Theodoros Rokkas, and Peter Malfertheiner. “Review: Prevention and management of gastric cancer.” In Helicobacter, 25 Suppl 1:e12740, 2020. https://doi.org/10.1111/hel.12740.Full Text Link to Item
-
Smith, Paul, Rowena Dolor, Anne C. Ford, Kristine Schmit, Kate Nisbet, Mary Ales, and Amanda Hoffmann. “Raising Awareness ... Starting the Conversation.” In Menopause the Journal of the North American Menopause Society, 23:1402–3. LIPPINCOTT WILLIAMS & WILKINS, 2016.Link to Item
-
-
-
Exhibitions, Screenings, & Performances
- Is Hormone Replacement Therapy Associated with REduced Risk of Adhesive Capsulitis in Menopausal Women? A Single Center Analysis | Poster presentation at Annual Meeting of the North American Menopause Society, Atlanta GA 2022
- Symptomatic Vulvovaginal Atrophy: Breaking Down Barriers to Identificatio and Treatment | North American Menopause Society Annual Meeting at Marriott Gaylord Convention Center, Orlando FL 2014
- Teaching & Mentoring
-
Advising & Mentoring
-
Duke Women's Health Wake County junior faculty mentor (9 new faculty members) 2018 - present
Duke Women's Health Wake County APP faculty advisor (8 new faculty members) 2018 - present
GYN faculty mentor, Primary Care Leadership Track Program, Duke University School of Medicine, 2010 -2018
Faculty Mentor to Ob/Gyn residents, 2012 to present
-
Duke Women's Health Wake County junior faculty mentor (9 new faculty members) 2018 - present
-
Teaching Activities
-
Ob/Gyn Resident Zoom Lecture Vulvar Diseases 11/18/2020
Menopause Zoom Lecture for Duke Nurse Practitioner Course April 23, 2020
Menopause Update - Lecture with Camille Moreno, DO to Duke Uroynecology Division, Fall 2019
Ob/Gyn Journal Club faculty sponser 2010 - 2020
Physician course director, Solving Your Tough Cases: Essential Musculoskeletal Assessment for Physicians and Advanced Practice Providers, Durham July 2017.
Lecturer, Southern Obstetric and Gynecologic Seminar Annual Meeting, Asheville, NC July 2012
Lecturer, 55th Annual University of SC Greenville Postgraduate Internal Medicine Seminar, Greenville, SC, April 2011
OB/Gyn Grand Rounds High Risk Breast Cancer Screening 1/2011
Community Lecture Teer House, Alternative Treatments for Menopausal Symptoms 5/2011
Menopause core lecture to first year medical students, 2008 -2011
University of SC CME Course: Internal Medicine Update 7/20210 Core faculty
AHEC: 4th Annual Women's Health Symposium, Menopausal Concerns 4/2010
NC Ob/Gyn Society Meeting, Greensboro,NC Bioidentical Hormone Therapy 3/2010
UNC Nursing Update: When Menorrhagia is more than a Gyn Problem, Chapel Hill NC 4/20110
Grand Rounds Maria Parham Hospital, Controversies Surrounding Menopausal Hormone Therapy 10/2009
Grand Rounds WakeMed Internal Medicine, Bioidential Hormone Therapy, 3/2009
AHEC 3rd Annual NC Women's Health Symposium, Female Sexual Function 3/2009
Ob/Gyn Grand Rounds, History and Emergence of Bioidentical Hormone Therapy 2009
Lecture Duke School of Nursing, Menopause: an Overview 11/2008
Duke Internal Medicine Video Conference with Diana McNeil, Menopause and other Health Concerns for the Mature Woman 2008
AHEC Pharmacotherapy Update: Women's Health 4/2008
Supervision of Duke OB/Gyn residents in OR and clinic 1998-2018
Supervision of MD, NP and PA students at Community Heath clinic, CAARE, providing breast and cervical cancer screening to underserved women 2008 - 2017
Supervision of PA students in clinic 2018 - present
-
- Scholarly, Clinical, & Service Activities
-
Presentations & Appearances
- Breast and Cervical Cancer Screening Update, and The Well Woman Visit - Do Asymptomatic Women Need Annual Gyn Exams? . 6th Annual Essentials in Primary Care Winter Conference. Contining Education Company. February 2018 2018
- HPV Vaccine (Gardasil)/Zoster Vaccine (Zostavax) Update andBreast and Cervical Cancer Screening- An Update, and The Well Woman Visit-Do Asymptomatic Women Need Annual Gyn Exams?. Medical Dilemmas in Patient Care Conference. Southern Medical Association. December 2017 2017
- Examining & Providing Gynecologic Care in the Older Patient. 100th Annual Conference Primary Care Update . IPMA. October 2016 2016
- Symptomatic Vulvovaginal Atrophy: Breaking Down Barriers to Identification and Treatment. 25th North American Menopause Society National Meeting. NAMS. October 2014 2014
- Menopausal Treatment – balancing risks/ benefits 10 years after WHI. Southern Obstetric and Gynecologic Seminar Annual Meeting . July 2014 2014
- Hormone Therapy: Good,Bad or In between?. 8th Annual Joining FORCEs Against Hereditary Cancer Conference. FORCE. June 2014 2014
- Menopausal Treatment Options. 55th Annual USC- Greenville Postgraduate Internal Medicine Seminar. University of SC School of Medicine. April 2011 2011
-
Outreach & Engaged Scholarship
-
Service to the Profession
- Judge, Poster session awards. North American Menopause Society Annual Meeting 2022. NAMS. October 20, 2022 2022
- Work group member. Wake County Infant Mortality Work Group. Wake County Board of Commissioners. September 2019 - January 2020 2019 - 2020
- Gynecology advisor. NC BCCCP Medical Advisory Committee . 2019 - 2022 2019 - 2022
- Gynecology Medical Director. CAARE Inc. same. 2008 - 2017 2008 - 2017
-
Service to Duke
-
Academic & Administrative Activities
-
Duke Ob/Gyn Departmental Clinical Leadership Team - 8/2020 - present
WakeMed North Hospital Services Executive Committee, 2/2019 - present
Duke OB/Gyn Quality, Safety, and Peer Review Committee, 2018 -- present
Clinical Sciences Faculty Council 6/2008 -- presentICGME Committee 7/02 – 7/04
Clinical Ethics Service 6/00 – 6/02
-
-
Clinical Activities
- Full time physician with Duke Women's Health Heritage, an academic generalist Ob/Gyn practice within Duke University School of Medicine. In addition to patient care responsibilities, other duties include oversight of Ob/Gyn student clinical education in the Wake County Ob/Gyn practices.
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.